Rak płuca
Leczenie

Leczenie raka płuca wymaga zindywidualizowanego podejścia uwzględniającego typ histologiczny, stadium zaawansowania, obecność mutacji molekularnych oraz stan ogólny pacjenta. W niedrobnokomórkowym raku płuca (NDRP) podstawą terapii we wczesnych stadiach jest chirurgia (lobektomia, segmentektomia), a u pacjentów niekwalifikujących się do operacji stosuje się stereotaktyczną radioterapię ciała (SBRT). W miejscowo zaawansowanym stadium IIIA/B standardem jest jednoczesna chemioradioterapia z następową immunoterapią konsolidującą (durwalumab). W stadium IV leczenie systemowe dobierane jest na podstawie profilu molekularnego guza – inhibitory EGFR, ALK, ROS1, BRAF, NTRK, MET, RET lub immunoterapia (pembrolizumab, atezolizumab) w zależności od ekspresji PD-L1. Chemioterapia oparta na pochodnych platyny (cisplatyna, karboplatyna) pozostaje fundamentem terapii, często w skojarzeniu z innymi cytostatykami i immunoterapią. W drobnokomórkowym raku płuca (DRP) dominującą rolę odgrywa chemioradioterapia (cisplatyna + etopozyd) z immunoterapią (atezolizumab, durwalumab) oraz profilaktyczne napromienianie mózgowia (PCI). W przypadku nawrotu stosuje się chemioterapię drugiej linii i nowoczesne leki, np. lurbinectedin czy tarlatamab.

Rak płuca – Leczenie

Leczenie raka płuca wymaga indywidualnego podejścia uwzględniającego wiele czynników, takich jak typ histologiczny nowotworu, stadium zaawansowania, obecność mutacji genetycznych, ogólny stan zdrowia pacjenta oraz jego preferencje12. Decyzje terapeutyczne podejmowane są przez wielodyscyplinarny zespół medyczny, składający się z pulmonologów, torakochirurgów, onkologów klinicznych, radioterapeutów, radiologów i patologów3.

Leczenie chirurgiczne

Leczenie chirurgiczne pozostaje podstawową metodą terapii we wczesnych stadiach niedrobnokomórkowego raka płuca (NDRP). W przypadku drobnokomórkowego raka płuca (DRP) chirurgia rzadko jest stosowana, ponieważ w momencie rozpoznania choroba jest zwykle zaawansowana45.

Zakres resekcji płuca zależy od wielkości i lokalizacji guza oraz wydolności oddechowej pacjenta. Podstawowe typy zabiegów obejmują67:

  • Resekcję klinową (wedge resection) – usunięcie guza wraz z małym fragmentem otaczającego płuca8
  • Resekcję segmentarną (segmental resection) – usunięcie większego obszaru płuca9
  • Lobektomię – usunięcie całego płata płuca; stanowi standard leczenia w większości przypadków1011
  • Pneumonektomię – usunięcie całego płuca; wykonywana rzadziej, głównie ze względu na lokalizację guza1213
  • Sleeve lobectomy – bardziej złożona forma lobektomii, stosowana głównie przy centralnie zlokalizowanych guzach14

Nowoczesne techniki chirurgiczne, takie jak wideotorakoskopia (VATS) czy chirurgia robotyczna, pozwalają na mniej inwazyjne usunięcie guzów, co przekłada się na szybszą rekonwalescencję pacjentów i mniejszy ból pooperacyjny15. W trakcie operacji standardem jest również usunięcie węzłów chłonnych śródpiersia w celu oceny stopnia zaawansowania choroby16.

Radioterapia

Radioterapia wykorzystuje wysokoenergetyczne promieniowanie do niszczenia komórek nowotworowych. W leczeniu raka płuca stosowana jest w różnych sytuacjach klinicznych1718:

  • Jako leczenie radykalne we wczesnych stadiach NDRP u pacjentów niekwalifikujących się do leczenia operacyjnego19
  • W skojarzeniu z chemioterapią (tzw. radiochemioterapia) w miejscowo zaawansowanym NDRP20
  • Jako leczenie przedoperacyjne mające na celu zmniejszenie guza21
  • Jako leczenie pooperacyjne w celu zniszczenia pozostałych komórek nowotworowych22
  • Jako leczenie paliatywne w zaawansowanym stadium choroby, łagodzące objawy takie jak ból, krwioplucie czy duszność23
  • W profilaktyce przerzutów do mózgu w DRP (profilaktyczne napromienianie mózgowia, PCI)24

Współczesne techniki radioterapii pozwalają na precyzyjne dostarczenie wysokiej dawki promieniowania do guza przy minimalnym narażeniu zdrowych tkanek. Obejmują one2526:

  • Trójwymiarową radioterapię konformalna (3D-CRT)
  • Radioterapię z modulacją intensywności wiązki (IMRT)
  • Stereotaktyczną radioterapię ciała (SBRT) – szczególnie skuteczną we wczesnych stadiach NDRP u pacjentów niekwalifikujących się do leczenia operacyjnego
  • Terapię protonową – wykorzystującą wiązki protonów zamiast fotonów, co pozwala na jeszcze lepszą ochronę zdrowych tkanek
  • Brachyterapię – polegającą na umieszczeniu źródła promieniowania bezpośrednio w pobliżu guza lub w jego obrębie

Najczęstsze działania niepożądane radioterapii obejmują zmęczenie, zapalenie przełyku, trudności w połykaniu, kaszel, duszność oraz odczyny popromienne skóry2728.

Chemioterapia

Chemioterapia wykorzystuje leki cytotoksyczne do niszczenia komórek nowotworowych w całym organizmie. W raku płuca może być stosowana2930:

  • Jako leczenie uzupełniające (adiuwantowe) po operacji w celu zniszczenia ewentualnych mikroprzerzutów31
  • Jako leczenie przedoperacyjne (neoadiuwantowe) mające na celu zmniejszenie guza3233
  • W skojarzeniu z radioterapią w miejscowo zaawansowanym NDRP34
  • Jako podstawowe leczenie w zaawansowanym stadium choroby35
  • Jako główne leczenie w DRP, często w połączeniu z radioterapią3637

W leczeniu NDRP najczęściej stosowane są schematy oparte na pochodnych platyny (cisplatyna, karboplatyna) w połączeniu z innymi lekami, takimi jak3839:

  • Gemcytabina
  • Pemetreksed (stosowany głównie w raku niepłaskonabłonkowym)
  • Docetaksel
  • Paklitaksel
  • Winorelbina

W DRP standardowo stosuje się schemat zawierający etopozyd z cisplatyną lub karboplatyną4041.

Leczenie podtrzymujące (maintenance) może być stosowane po zakończeniu standardowej chemioterapii pierwszego rzutu w zaawansowanym NDRP, zwłaszcza u pacjentów, którzy odpowiedzieli na leczenie początkowe. Najczęściej stosowanym lekiem w terapii podtrzymującej jest pemetreksed42.

Najczęstsze działania niepożądane chemioterapii obejmują: nudności, wymioty, utratę apetytu, zmęczenie, obniżenie liczby krwinek (prowadzące do większej podatności na infekcje, krwawienia i anemię), wypadanie włosów oraz uszkodzenie nerwów obwodowych43.

Leczenie celowane

Terapie celowane ukierunkowane są na specyficzne zmiany molekularne występujące w komórkach nowotworowych, co pozwala na bardziej precyzyjne i mniej toksyczne leczenie. W NDRP najważniejsze cele molekularne to4445:

  • Mutacje w genie EGFR (receptor naskórkowego czynnika wzrostu) – stosowane są inhibitory kinazy tyrozynowej EGFR, takie jak erlotynib (Tarceva), gefitynib (Iressa), afatynib, dakomitynib i ozymertynib (Tagrisso)
  • Rearanżacje genu ALK – stosowane są inhibitory ALK, takie jak kryzotynib, alektynib, cerytynib, brygatynib i lorlatynib
  • Rearanżacje genu ROS1 – leczenie obejmuje kryzotynib, entrektynib i inne inhibitory ROS1
  • Mutacje BRAF V600E – stosowana jest kombinacja dabrafenibu (Tafinlar) i trametynibu (Mekinist)46
  • Fuzje NTRK – stosowane są larotrektynib i entrektynib
  • Mutacje w eksonie 14 genu MET – stosowane są inhibitory MET, takie jak tepotynib i kapmatynib
  • Rearanżacje genu RET – stosowane są selperkatynib i pralsetynib

W celu identyfikacji pacjentów, którzy mogą skorzystać z terapii celowanej, niezbędne jest przeprowadzenie kompleksowych badań molekularnych próbki guza47. Leczenie celowane może być stosowane w pierwszej linii leczenia zaawansowanego NDRP u pacjentów z potwierdzonymi zmianami molekularnymi, w leczeniu uzupełniającym po operacji u pacjentów z wczesnym stadium choroby i specyficznymi mutacjami (np. EGFR), a także w kolejnych liniach leczenia po niepowodzeniu chemioterapii48.

Immunoterapia

Immunoterapia to innowacyjna strategia leczenia, która stymuluje układ odpornościowy pacjenta do rozpoznawania i niszczenia komórek nowotworowych4950. W leczeniu raka płuca najważniejszą grupę leków immunoterapeutycznych stanowią inhibitory punktów kontrolnych układu immunologicznego, takie jak5152:

  • Inhibitory PD-1: pembrolizumab (Keytruda), niwolumab (Opdivo)
  • Inhibitory PD-L1: atezolizumab (Tecentriq), durwalumab (Imfinzi), avelumab (Bavencio)
  • Inhibitory CTLA-4: ipilimumab (Yervoy)

Immunoterapia może być stosowana5354:

  • W monoterapii w pierwszej linii leczenia zaawansowanego NDRP u pacjentów z wysoką ekspresją PD-L1 (≥50%)
  • W skojarzeniu z chemioterapią w pierwszej linii leczenia zaawansowanego NDRP, niezależnie od ekspresji PD-L1
  • W kolejnych liniach leczenia zaawansowanego NDRP po niepowodzeniu chemioterapii
  • W leczeniu uzupełniającym po radiochemioterapii w miejscowo zaawansowanym, nieresekcyjnym NDRP
  • W leczeniu uzupełniającym po resekcji chirurgicznej we wczesnym stadium NDRP z wysokim ryzykiem nawrotu
  • W skojarzeniu z chemioterapią w pierwszej linii leczenia zaawansowanego DRP

W DRP stosuje się atezolizumab i durwalumab w połączeniu z chemioterapią jako leczenie pierwszej linii w chorobie w stadium rozległym5556.

Najnowszym osiągnięciem w immunoterapii DRP jest zatwierdzenie przez FDA leku tarlatamab (Imdelltra) do leczenia DRP w stadium rozległym, który uległ progresji po chemioterapii opartej na pochodnych platyny. Ten lek jest przeciwciałem skierowanym przeciwko białku DLL3 na komórkach nowotworowych, co pomaga układowi odpornościowemu zidentyfikować i zniszczyć komórki rakowe57.

Działania niepożądane immunoterapii różnią się od tych obserwowanych podczas chemioterapii i obejmują głównie reakcje autoimmunologiczne, takie jak zapalenie płuc, zapalenie jelita grubego, zapalenie wątroby, zapalenie przysadki, zapalenie tarczycy i inne zaburzenia endokrynologiczne58.

Leczenie skojarzone

Leczenie skojarzone, łączące różne metody terapeutyczne, jest często stosowane w raku płuca w celu poprawy wyników leczenia5960:

  • Chemioradioterapia (jednoczesna lub sekwencyjna) – standardowe podejście w miejscowo zaawansowanym, nieresekcyjnym NDRP oraz w DRP w stadium ograniczonym6162
  • Leczenie neoadiuwantowe (przedoperacyjne) – chemioterapia, immunoterapia lub ich kombinacja przed zabiegiem chirurgicznym6364
  • Leczenie adiuwantowe (pooperacyjne) – chemioterapia, radioterapia, immunoterapia lub terapia celowana po zabiegu chirurgicznym6566
  • Chemioterapia w skojarzeniu z immunoterapią – standardowe podejście w pierwszej linii leczenia zaawansowanego NDRP oraz DRP w stadium rozległym6768
  • Terapia celowana w skojarzeniu z chemioterapią – stosowana w niektórych podtypach molekularnych NDRP69

Leczenie w zależności od typu i stadium raka płuca

Niedrobnokomórkowy rak płuca (NDRP)

Leczenie NDRP zależy od stadium zaawansowania choroby7071:

  • Stadium 0 (rak in situ): leczenie operacyjne (resekcja klinowa lub segmentarna), w przypadku przeciwwskazań do operacji – metody ablacyjne (fotokoagulacja laserowa, elektrokoagulacja, krioterapia)72
  • Stadium I: podstawowym leczeniem jest operacja (lobektomia, segmentektomia); u pacjentów niekwalifikujących się do leczenia operacyjnego – stereotaktyczna radioterapia (SBRT); w przypadku wysokiego ryzyka nawrotu – rozważenie leczenia uzupełniającego chemioterapią, immunoterapią lub terapią celowaną7374
  • Stadium II: leczenie operacyjne (lobektomia, pneumonektomia) z następową chemioterapią adiuwantową (ewentualnie w skojarzeniu z immunoterapią); w przypadku wysokiego ryzyka nawrotu możliwe zastosowanie terapii celowanej (np. ozymertynib u pacjentów z mutacją EGFR); u pacjentów niekwalifikujących się do leczenia operacyjnego – radioterapia radykalna7576
  • Stadium IIIA: postępowanie zależy od możliwości resekcji; u pacjentów z chorobą resekcyjną – leczenie operacyjne poprzedzone chemioterapią neoadiuwantową (z immunoterapią lub bez) lub leczenie operacyjne z następową chemioterapią i radioterapią; u pacjentów z chorobą nieresekcyjną – jednoczesna chemioradioterapia7778
  • Stadium IIIB/IIIC: jednoczesna chemioradioterapia z następową immunoterapią konsolidującą (durwalumab) u pacjentów z odpowiedzią lub stabilizacją po chemioradioterapii7980
  • Stadium IV: leczenie systemowe dostosowane do podtypu molekularnego i histologicznego: u pacjentów z określonymi zmianami molekularnymi (EGFR, ALK, ROS1, BRAF, NTRK, MET, RET) – odpowiednia terapia celowana; u pacjentów bez zmian molekularnych – immunoterapia w monoterapii (przy wysokiej ekspresji PD-L1) lub w skojarzeniu z chemioterapią; paliatywna radioterapia w celu łagodzenia objawów818283

Drobnokomórkowy rak płuca (DRP)

Leczenie DRP zależy od stadium zaawansowania, które tradycyjnie dzieli się na8485:

  • Stadium ograniczone (choroba ograniczona do jednej połowy klatki piersiowej): podstawą leczenia jest jednoczesna chemioradioterapia (schemat PE: cisplatyna + etopozyd) z ewentualną immunoterapią konsolidującą; po uzyskaniu odpowiedzi na leczenie stosuje się profilaktyczne napromienianie mózgowia (PCI); w bardzo wczesnym stadium można rozważyć leczenie operacyjne868788
  • Stadium rozległe (choroba wykraczająca poza jedną połowę klatki piersiowej): chemioterapia oparta na schemacie PE (cisplatyna + etopozyd) w skojarzeniu z immunoterapią (atezolizumab lub durwalumab); w przypadku odpowiedzi na leczenie można rozważyć PCI oraz paliatywną radioterapię na obszar klatki piersiowej899091

W przypadku nawrotu DRP stosuje się chemioterapię drugiej linii (topotekan, irynotekan, paklitaksel, docetaksel, gemcytabina lub kombinacje tych leków), a także nowoczesne leki takie jak lurbinectedin (Zepzelca)9293. U pacjentów z nawrotem po ponad 6 miesiącach od zakończenia pierwszej linii leczenia można rozważyć ponowne zastosowanie schematu opartego na pochodnych platyny94.

Leczenie paliatywne i wspomagające

Opieka paliatywna i wspomagająca jest istotnym elementem kompleksowego leczenia raka płuca, mającym na celu łagodzenie objawów choroby oraz działań niepożądanych leczenia przeciwnowotworowego9596.

Najważniejsze metody leczenia paliatywnego w raku płuca obejmują9798:

  • Paliatywną radioterapię – stosowaną w celu łagodzenia bólu, krwioplucia, duszności czy objawów neurologicznych związanych z przerzutami do mózgu lub uciskiem na rdzeń kręgowy99
  • Metody endoskopowe – laseroterapię, krioterapię, elektrokoagulację, brachyterapię wewnątrzoskrzelową – stosowane w przypadku zwężenia dróg oddechowych przez guz100101
  • Stentowanie dróg oddechowych – stosowane w celu utrzymania drożności oskrzeli w przypadku zwężenia przez guz102
  • Drenaż opłucnowy i pleurodezę – w przypadku wysięku w opłucnej powodującego duszność103
  • Leczenie przeciwbólowe – odpowiednio dobrane do natężenia bólu, zgodnie z drabiną analgetyczną WHO104
  • Leczenie objawowe – przeciwkaszlowe, przeciwwymiotne, przeciwdepresyjne, przeciwlękowe i inne, w zależności od występujących objawów105

Wczesne włączenie opieki paliatywnej, równolegle z leczeniem onkologicznym, może poprawić jakość życia pacjentów z zaawansowanym rakiem płuca, a nawet wydłużyć czas przeżycia106107.

Badania kliniczne

Badania kliniczne stanowią istotną opcję terapeutyczną dla pacjentów z rakiem płuca, oferując dostęp do innowacyjnych metod leczenia, które nie są jeszcze powszechnie dostępne108109.

Obecnie prowadzone badania kliniczne w raku płuca koncentrują się na110111:

  • Nowych lekach immunoterapeutycznych i ich kombinacjach z istniejącymi terapiami
  • Nowych terapiach celowanych ukierunkowanych na rzadkie mutacje i mechanizmy oporności
  • Koniugatach przeciwciało-lek (ADC), które dostarczają cytostatyk bezpośrednio do komórek nowotworowych112
  • Stosowaniu immunoterapii i terapii celowanych we wcześniejszych stadiach choroby
  • Zindywidualizowanych schematach leczenia opartych na profilowaniu molekularnym guza
  • Nowych metodach leczenia skojarzonego mających na celu poprawę wyników leczenia i zmniejszenie toksyczności

Udział w badaniu klinicznym powinien być rozważony na każdym etapie leczenia raka płuca, a szczególnie w przypadku zaawansowanej choroby lub po niepowodzeniu standardowych metod leczenia113114.

Znaczenie zaprzestania palenia

Zaprzestanie palenia tytoniu jest istotnym elementem leczenia raka płuca. Badania wykazały, że pacjenci, którzy przestają palić po rozpoznaniu raka płuca, mają lepsze wyniki leczenia niż ci, którzy kontynuują palenie115116.

Korzyści z zaprzestania palenia u pacjentów z rakiem płuca obejmują117118:

  • Lepszą skuteczność leczenia przeciwnowotworowego
  • Zmniejszone ryzyko powikłań pooperacyjnych
  • Lepszą tolerancję chemioterapii i radioterapii
  • Zmniejszone ryzyko rozwoju drugiego pierwotnego nowotworu
  • Poprawę ogólnego stanu zdrowia i jakości życia

Pacjentom z rakiem płuca należy oferować wsparcie w zaprzestaniu palenia, w tym poradnictwo, farmakoterapię (np. nikotynowa terapia zastępcza, bupropion, wareniklina) oraz udział w programach odwykowych119.

Podsumowanie strategii leczenia raka płuca

Stadium Niedrobnokomórkowy rak płuca (NDRP) Drobnokomórkowy rak płuca (DRP)
Wczesne stadium (I-II) – Leczenie chirurgiczne (lobektomia)
– W przypadku przeciwwskazań: SBRT
– Rozważenie chemioterapii adiuwantowej
– U wybranych pacjentów: immunoterapia adiuwantowa lub terapia celowana
– Rzadko wykrywany we wczesnym stadium
– W wybranych przypadkach: leczenie chirurgiczne
– Chemioradioterapia
– Profilaktyczne napromienianie mózgowia (PCI)
Stadium miejscowo zaawansowane (III) – IIIA resekcyjne: operacja + chemioterapia (neo)adiuwantowa
– IIIA/B nieresekcyjne: jednoczesna chemioradioterapia
– Po chemioradioterapii: immunoterapia konsolidująca (durwalumab)
– Jednoczesna chemioradioterapia
– Profilaktyczne napromienianie mózgowia (PCI)
– Rozważenie immunoterapii konsolidującej
Stadium zaawansowane (IV) – Z mutacjami kierującymi: odpowiednia terapia celowana
– Bez mutacji kierujących, wysoka ekspresja PD-L1: immunoterapia
– Niska ekspresja PD-L1: chemioterapia + immunoterapia
– Leczenie paliatywne w celu łagodzenia objawów
– Chemioterapia (PE) + immunoterapia (atezolizumab/durwalumab)
– Rozważenie PCI przy dobrej odpowiedzi
– Paliatywna radioterapia
– W nawrocie: chemioterapia drugiej linii, lurbinectedin, tarlatamab

Skuteczne leczenie raka płuca wymaga indywidualnego podejścia i ścisłej współpracy wielodyscyplinarnego zespołu medycznego. Postęp w dziedzinie onkologii, w tym rozwój terapii celowanych i immunoterapii, przyczynił się do znaczącej poprawy wyników leczenia i jakości życia pacjentów z rakiem płuca. Kluczowe znaczenie ma wczesne rozpoznanie choroby oraz kompleksowa ocena molekularna guza, umożliwiająca dobór optymalnej strategii terapeutycznej120121.

Kolejne rozdziały

Zapraszamy do dalszego czytania naszego leksykonu.

Wybierz kolejny rozdział z menu poniżej, aby otworzyć nową podstronę kompedium wiedzy i uzyskać szczegółowe informację o leku, substancji lub chorobie.

  1. 13.04.2026
  2. www.leksykon.com.pl

Materiały źródłowe

  • #1 Lung cancer – Diagnosis and treatment – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/lung-cancer/diagnosis-treatment/drc-20374627
    Treatment for lung cancer usually begins with surgery to remove the cancer. If the cancer is very large or has spread to other parts of the body, surgery may not be possible. Treatment might start with medicine and radiation instead. Your healthcare team considers many factors when creating a treatment plan. These factors may include your overall health, the type and stage of your cancer, and your preferences. […] Some people with lung cancer choose not to have treatment. For instance, you may feel that the side effects of treatment will outweigh the potential benefits. When that’s the case, your healthcare professional may suggest comfort care to treat only the symptoms the cancer is causing. […] Lung cancer surgery can involve removing a portion of the lung or the entire lung. An operation to remove the lung cancer and a small portion of healthy tissue is called a wedge resection. Removing a larger area of the lung is called segmental resection. Surgery to remove one lobe from a lung is called lobectomy. Removing an entire lung is called pneumonectomy.
  • #2
    https://www.nhs.uk/conditions/lung-cancer/treatment/
    Treatment for lung cancer is managed by a team of specialists from different departments who work together to provide the best possible treatment. […] The type of treatment you receive for lung cancer depends on several factors, including: the type of lung cancer you have (non-small-cell or small-cell mutations on the cancer), the size and position of the cancer, how advanced your cancer is (the stage), your overall health. […] The most common treatment options include surgery, radiotherapy, chemotherapy and immunotherapy. Depending on the type of cancer and the stage, you may receive a combination of these treatments. […] If you have non-small-cell lung cancer that’s in only 1 of your lungs and you’re in good general health, you’ll probably have surgery to remove the cancerous cells.
  • #3 Treatment for lung cancer | Cancer Research UK
    https://www.cancerresearchuk.org/about-cancer/lung-cancer/treatment
    Your treatment depends on several factors. These include what type of lung cancer you have, how big it is and whether it has spread (the stage). It also depends on your general health. […] A team of health professionals decides what treatment you might need. They also decide what treatment options you have. The type of treatment you have for small cell lung cancer will depend on the stage of your cancer. […] The type of treatment you have for non small cell lung cancer will depend on the stage of your cancer. […] The type of surgery you might have depends on where in the lung your cancer is, how big it is, and your general health. […] Radiotherapy is a common treatment for lung cancer. You usually have external radiotherapy. This means using radiation from a machine to destroy the cancer.
  • #4 Lung Cancer Treatment Program | Massachusetts General Hospital
    https://www.massgeneral.org/cancer-center/treatments-and-services/thoracic-cancers/lung-cancer
    Your multidisciplinary care team will develop a personalized treatment plan based on your needs and goals. They will support and guide you through every step of receiving chemo for lung cancer. […] Our team of dedicated surgeons treats some of the most challenging and complex cases from across the US. […] Specialists in the Thoracic Radiation Oncology Program employ high-precision radiation therapy to treat patients with lung cancers and other cancers in the chest with the overarching goal of causing little or no side effects. […] Early-stage non-small cell lung cancer may involve surgery to remove the tumors, or other therapies like immunotherapy, chemotherapy, targeted therapy, radiation therapy, and thermal ablation. […] Metastatic lung cancer treatment typically aims to minimize symptoms, improve quality of life, and help patients live longer. This might be achieved through chemotherapy, radiotherapy, immunotherapy, and targeted therapy. […] Clinical trials are research studies which are conducted to answer questions. […] Our program has a very active clinical research portfolio with the latest, top-notch investigational studies covering a wide spectrum of thoracic cancer care.
  • #5 Treatment for Lung Cancer | Fred Hutchinson Cancer Center
    https://www.fredhutch.org/en/diseases/lung-cancer/treatment.html
    Many people with lung cancer have radiation therapy alone or along with other treatments. It is painless and noninvasive, and each treatment lasts only minutes. […] Different types of radiation treatments are used for different situations. […] Fred Hutch patients have surgery at UW Medical Center – Montlake with thoracic surgeons who are among the best in the country. […] For early-stage non-small cell lung cancer, surgery to remove the cancer may be an option. When it is an option, it provides the best chance for a cure. […] For small cell lung cancer, doctors rarely use surgery because by the time the disease is found it has often spread too far for surgery to be effective. […] These surgeries are typically used to treat lung cancer. […] Targeted therapies are newer cancer treatments that work more selectively than standard chemotherapy. These medicines are used most often in people with advanced and recurrent lung cancer and are effective in patients with specific changes in their tumor genes.
  • #6 Lung cancer – Diagnosis and treatment – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/lung-cancer/diagnosis-treatment/drc-20374627
    Treatment for lung cancer usually begins with surgery to remove the cancer. If the cancer is very large or has spread to other parts of the body, surgery may not be possible. Treatment might start with medicine and radiation instead. Your healthcare team considers many factors when creating a treatment plan. These factors may include your overall health, the type and stage of your cancer, and your preferences. […] Some people with lung cancer choose not to have treatment. For instance, you may feel that the side effects of treatment will outweigh the potential benefits. When that’s the case, your healthcare professional may suggest comfort care to treat only the symptoms the cancer is causing. […] Lung cancer surgery can involve removing a portion of the lung or the entire lung. An operation to remove the lung cancer and a small portion of healthy tissue is called a wedge resection. Removing a larger area of the lung is called segmental resection. Surgery to remove one lobe from a lung is called lobectomy. Removing an entire lung is called pneumonectomy.
  • #7 6 Innovative Lung Cancer Treatment Options | MD Anderson Cancer Center
    https://www.mdanderson.org/cancer-types/lung-cancer/lung-cancer-treatment.html
    Your treatment for lung cancer will be customized to your particular needs. It may include one or more of the following therapies to treat the cancer and help relieve symptoms. […] Surgery may be a good option for those with early-stage non-small cell lung cancer. In some cases, patients may receive chemotherapy or radiation before surgery to shrink the tumor. This is called neoadjuvant therapy. […] The most common types of surgery for lung cancer, in order of the amount of lung tissue removed, are: Wedge resection: Removal of the tumor and a pie- or wedge-shaped piece of the lung around the tumor. […] Segmentectomy or segmental resection: Removal of a segment, or part, of the lobe where the cancer is located. […] Lobectomy: Removal of the lung lobe where the cancer is located. This is considered the standard of care for most lung cancer patients who undergo surgery.
  • #8 Lung cancer – Diagnosis and treatment – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/lung-cancer/diagnosis-treatment/drc-20374627
    Treatment for lung cancer usually begins with surgery to remove the cancer. If the cancer is very large or has spread to other parts of the body, surgery may not be possible. Treatment might start with medicine and radiation instead. Your healthcare team considers many factors when creating a treatment plan. These factors may include your overall health, the type and stage of your cancer, and your preferences. […] Some people with lung cancer choose not to have treatment. For instance, you may feel that the side effects of treatment will outweigh the potential benefits. When that’s the case, your healthcare professional may suggest comfort care to treat only the symptoms the cancer is causing. […] Lung cancer surgery can involve removing a portion of the lung or the entire lung. An operation to remove the lung cancer and a small portion of healthy tissue is called a wedge resection. Removing a larger area of the lung is called segmental resection. Surgery to remove one lobe from a lung is called lobectomy. Removing an entire lung is called pneumonectomy.
  • #9 Lung cancer – Diagnosis and treatment – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/lung-cancer/diagnosis-treatment/drc-20374627
    Treatment for lung cancer usually begins with surgery to remove the cancer. If the cancer is very large or has spread to other parts of the body, surgery may not be possible. Treatment might start with medicine and radiation instead. Your healthcare team considers many factors when creating a treatment plan. These factors may include your overall health, the type and stage of your cancer, and your preferences. […] Some people with lung cancer choose not to have treatment. For instance, you may feel that the side effects of treatment will outweigh the potential benefits. When that’s the case, your healthcare professional may suggest comfort care to treat only the symptoms the cancer is causing. […] Lung cancer surgery can involve removing a portion of the lung or the entire lung. An operation to remove the lung cancer and a small portion of healthy tissue is called a wedge resection. Removing a larger area of the lung is called segmental resection. Surgery to remove one lobe from a lung is called lobectomy. Removing an entire lung is called pneumonectomy.
  • #10 Lung cancer – Diagnosis and treatment – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/lung-cancer/diagnosis-treatment/drc-20374627
    Treatment for lung cancer usually begins with surgery to remove the cancer. If the cancer is very large or has spread to other parts of the body, surgery may not be possible. Treatment might start with medicine and radiation instead. Your healthcare team considers many factors when creating a treatment plan. These factors may include your overall health, the type and stage of your cancer, and your preferences. […] Some people with lung cancer choose not to have treatment. For instance, you may feel that the side effects of treatment will outweigh the potential benefits. When that’s the case, your healthcare professional may suggest comfort care to treat only the symptoms the cancer is causing. […] Lung cancer surgery can involve removing a portion of the lung or the entire lung. An operation to remove the lung cancer and a small portion of healthy tissue is called a wedge resection. Removing a larger area of the lung is called segmental resection. Surgery to remove one lobe from a lung is called lobectomy. Removing an entire lung is called pneumonectomy.
  • #11 6 Innovative Lung Cancer Treatment Options | MD Anderson Cancer Center
    https://www.mdanderson.org/cancer-types/lung-cancer/lung-cancer-treatment.html
    Your treatment for lung cancer will be customized to your particular needs. It may include one or more of the following therapies to treat the cancer and help relieve symptoms. […] Surgery may be a good option for those with early-stage non-small cell lung cancer. In some cases, patients may receive chemotherapy or radiation before surgery to shrink the tumor. This is called neoadjuvant therapy. […] The most common types of surgery for lung cancer, in order of the amount of lung tissue removed, are: Wedge resection: Removal of the tumor and a pie- or wedge-shaped piece of the lung around the tumor. […] Segmentectomy or segmental resection: Removal of a segment, or part, of the lobe where the cancer is located. […] Lobectomy: Removal of the lung lobe where the cancer is located. This is considered the standard of care for most lung cancer patients who undergo surgery.
  • #12 Lung cancer – Diagnosis and treatment – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/lung-cancer/diagnosis-treatment/drc-20374627
    Treatment for lung cancer usually begins with surgery to remove the cancer. If the cancer is very large or has spread to other parts of the body, surgery may not be possible. Treatment might start with medicine and radiation instead. Your healthcare team considers many factors when creating a treatment plan. These factors may include your overall health, the type and stage of your cancer, and your preferences. […] Some people with lung cancer choose not to have treatment. For instance, you may feel that the side effects of treatment will outweigh the potential benefits. When that’s the case, your healthcare professional may suggest comfort care to treat only the symptoms the cancer is causing. […] Lung cancer surgery can involve removing a portion of the lung or the entire lung. An operation to remove the lung cancer and a small portion of healthy tissue is called a wedge resection. Removing a larger area of the lung is called segmental resection. Surgery to remove one lobe from a lung is called lobectomy. Removing an entire lung is called pneumonectomy.
  • #13 6 Innovative Lung Cancer Treatment Options | MD Anderson Cancer Center
    https://www.mdanderson.org/cancer-types/lung-cancer/lung-cancer-treatment.html
    Sleeve lobectomy: A more complex form of lobectomy that is typically used for centrally located tumors. […] Pneumonectomy: Removal of an entire lung. This surgery is occasionally required due to the location of the tumor. […] Treatment following surgery is called adjuvant therapy. […] Radiation therapy uses focused, high-energy photon beams to destroy lung cancer cells. […] The radiation therapy treatments used for lung cancer patients include: 3D-conformal radiation therapy: Several radiation beams are given in the exact shape of the tumor. […] Intensity-modulate radiotherapy (IMRT): Treatment is tailored to the specific shape of the tumor. […] Stereotactic body radiation therapy (SBRT): High doses of radiation delivered with several beams at various intensities and angles to precisely target the tumor.
  • #14 6 Innovative Lung Cancer Treatment Options | MD Anderson Cancer Center
    https://www.mdanderson.org/cancer-types/lung-cancer/lung-cancer-treatment.html
    Sleeve lobectomy: A more complex form of lobectomy that is typically used for centrally located tumors. […] Pneumonectomy: Removal of an entire lung. This surgery is occasionally required due to the location of the tumor. […] Treatment following surgery is called adjuvant therapy. […] Radiation therapy uses focused, high-energy photon beams to destroy lung cancer cells. […] The radiation therapy treatments used for lung cancer patients include: 3D-conformal radiation therapy: Several radiation beams are given in the exact shape of the tumor. […] Intensity-modulate radiotherapy (IMRT): Treatment is tailored to the specific shape of the tumor. […] Stereotactic body radiation therapy (SBRT): High doses of radiation delivered with several beams at various intensities and angles to precisely target the tumor.
  • #15 New Lung Cancer Treatments Aim to Reduce Deaths in 2025 and Beyond | Memorial Sloan Kettering Cancer Center
    https://www.mskcc.org/news/new-lung-cancer-treatments-aim-to-reduce-deaths-in-2025-and-beyond
    Thoracic medical oncologist Dr. Mark Awad says new treatments for lung cancer include a growing number of targeted therapies and new forms of immunotherapy. […] Exciting new treatments have emerged in recent years both for early-stage tumors (stage 1, 2, or 3) that can be surgically removed, and for more advanced stage 4 lung cancers that have spread (metastasized). […] At MSK, more than 90% of lung cancer surgeries for early-stage disease (stage 1) now use minimally invasive approaches such as video-assisted thoracic surgery (VATS) and robotic-assisted surgery. This usually results in less pain and fewer complications. It also enables patients who may need chemotherapy or radiation therapy to start treatment sooner. […] For people with later-stage cancers, many new treatment options have been developed. These include new chemotherapy treatments, new targeted therapies that are matched to specific genetic mutations found within the lung cancer tumor, new immunotherapies, and novel cellular treatments.
  • #16 Lung cancer – Diagnosis and treatment – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/lung-cancer/diagnosis-treatment/drc-20374627
    If you have surgery, your surgeon also may remove lymph nodes from your chest to test them for cancer. […] Surgery may be an option if your cancer is only in the lungs. If you have a larger lung cancer, chemotherapy or radiation therapy may be used before surgery to shrink the cancer. Chemotherapy or radiation therapy also may be used after surgery if there’s a risk that cancer cells were left behind or that your cancer may come back. […] Radiation therapy treats cancer with powerful energy beams. The energy can come from X-rays, protons or other sources. During radiation therapy, you lie on a table while a machine moves around you. The machine directs radiation to precise points on your body. […] For lung cancer that has spread within the chest, radiation may be used before surgery or after surgery. It’s often combined with chemotherapy treatments. If surgery isn’t an option, combined chemotherapy and radiation therapy may be your first treatment.
  • #17 Lung cancer – Diagnosis and treatment – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/lung-cancer/diagnosis-treatment/drc-20374627
    If you have surgery, your surgeon also may remove lymph nodes from your chest to test them for cancer. […] Surgery may be an option if your cancer is only in the lungs. If you have a larger lung cancer, chemotherapy or radiation therapy may be used before surgery to shrink the cancer. Chemotherapy or radiation therapy also may be used after surgery if there’s a risk that cancer cells were left behind or that your cancer may come back. […] Radiation therapy treats cancer with powerful energy beams. The energy can come from X-rays, protons or other sources. During radiation therapy, you lie on a table while a machine moves around you. The machine directs radiation to precise points on your body. […] For lung cancer that has spread within the chest, radiation may be used before surgery or after surgery. It’s often combined with chemotherapy treatments. If surgery isn’t an option, combined chemotherapy and radiation therapy may be your first treatment.
  • #18 Lung Cancer Treatment
    https://www.radiologyinfo.org/en/info/lung-cancer-therapy
    Lung cancer is a leading cause of cancer-related death in the United States. If detected early enough, it can often be successfully treated. […] Doctors use medical imaging to determine the stage of the tumor. Treatment options (and their expected results) depend on the stage of the tumor. […] Your doctor may treat early-stage lung cancer with standard treatments such as surgery or radiation therapy. […] Surgery is the primary treatment for patients with early-stage cancer who are in good general health. The goal of surgery is to totally remove all the tumor cells and thereby provide a cure. […] Radiation therapy (radiotherapy) uses high-energy x-rays to destroy cancer cells and to ease symptoms. Doctors use it as primary treatment, before surgery to shrink the tumor, after surgery to eliminate any cancer cells that remain in the treated area, and to treat lung cancer that has spread to the brain or other areas of the body or to ease symptoms.
  • #19
    https://www.nhs.uk/conditions/lung-cancer/treatment/
    You may also have chemotherapy or immunotherapy treatment before or after surgery. […] If the cancer has not spread far but surgery is not possible, you may be offered radiotherapy to destroy the cancerous cells. […] If the cancer has spread too far for surgery or radiotherapy to be effective, chemotherapy and/or immunotherapy is usually recommended. […] Small-cell lung cancer is usually treated with chemotherapy, either on its own or in combination with radiotherapy or immunotherapy. […] Surgery is not usually used to treat this type of lung cancer. […] Radiotherapy uses pulses of radiation to destroy cancer cells. […] An intensive course of radiotherapy, known as radical radiotherapy, may be used to treat non-small-cell lung cancer if you are not healthy enough for surgery. […] Chemotherapy uses powerful cancer-killing medicine to treat cancer.
  • #20 Radiation therapy for lung cancer | Canadian Cancer Society
    https://cancer.ca/en/cancer-information/cancer-types/lung/treatment/radiation-therapy
    Radiation therapy uses high-energy rays or particles to destroy cancer cells. Most people with lung cancer have radiation therapy. Your healthcare team will consider your personal needs to plan the type and amount of radiation, and when and how it is given. You may also receive other treatments. […] Radiation therapy is often combined with chemotherapy to treat lung cancer. This is called chemoradiation. The 2 treatments are given during the same time period. You will not be offered chemoradiation if you aren’t healthy enough to have this type of treatment. […] Radiation therapy is given for different reasons. You may have radiation therapy or chemoradiation: as the main treatment for lung cancer that can’t be removed with surgery, or if you don’t want to have surgery; after surgery to lower the risk of the cancer coming back (recurring) (called adjuvant therapy); to relieve pain or control the symptoms of advanced lung cancer (called palliative therapy); to treat lung cancer that has spread to the brain (brain metastases); to prevent small cell lung cancer from spreading in the brain.
  • #21 Lung cancer – Diagnosis and treatment – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/lung-cancer/diagnosis-treatment/drc-20374627
    If you have surgery, your surgeon also may remove lymph nodes from your chest to test them for cancer. […] Surgery may be an option if your cancer is only in the lungs. If you have a larger lung cancer, chemotherapy or radiation therapy may be used before surgery to shrink the cancer. Chemotherapy or radiation therapy also may be used after surgery if there’s a risk that cancer cells were left behind or that your cancer may come back. […] Radiation therapy treats cancer with powerful energy beams. The energy can come from X-rays, protons or other sources. During radiation therapy, you lie on a table while a machine moves around you. The machine directs radiation to precise points on your body. […] For lung cancer that has spread within the chest, radiation may be used before surgery or after surgery. It’s often combined with chemotherapy treatments. If surgery isn’t an option, combined chemotherapy and radiation therapy may be your first treatment.
  • #22 Radiation Therapy for Lung Cancer | American Lung Association
    https://www.lung.org/lung-health-diseases/lung-disease-lookup/lung-cancer/treatment/types-of-treatment/radiation-therapy
    Radiation is a type of lung cancer treatment designed to only target cancer cells and not affect other parts of the body. […] Lung cancer radiation therapy uses powerful, high-energy X-rays to kill cancer cells or keep them from growing. […] During radiation. Radiation is designed to only target cancer cells and not affect other parts of the body. […] There are different types of radiation for lung cancer. All types kill cancer cells or stop them from growing. […] Radiation can be used before lung cancer surgery to shrink the tumor or after surgery to kill any cancer cells left in the lungs. […] Radiation therapy for lung cancer also can be used to relieve symptoms caused by the cancer, such as pain, bleeding or blockage of airways by the tumor. […] Sometimes patients with small cell lung cancer (SCLC) will get radiation to the brain. This helps to lower the chances of the lung cancer spreading to the brain, which is common in SCLC. […] Doctors use several different radiation techniques to administer therapy. […] Discuss concerns, possible side effects and any effects that you experience with your doctor.
  • #23 Lung cancer – Diagnosis and treatment – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/lung-cancer/diagnosis-treatment/drc-20374627
    Chemotherapy treats cancer with strong medicines. Many chemotherapy medicines exist. Most are given through a vein. Some come in pill form. A combination of medicines usually is given in a series of treatments over a period of weeks or months. Breaks in between are used to help you recover. […] Chemotherapy is often used after surgery to kill any cancer cells that may remain. It can be used alone or combined with radiation therapy. Chemotherapy also may be used before surgery to shrink cancers and make them easier to remove. […] For lung cancers that have spread to other areas of the body, radiation therapy may help relieve symptoms. […] Targeted therapy for cancer is a treatment that uses medicines that attack specific chemicals in the cancer cells. By blocking these chemicals, targeted treatments can cause cancer cells to die. For lung cancer, targeted therapy may be used for people with cancer that spreads or comes back after treatment.
  • #24 Radiation therapy for lung cancer | Canadian Cancer Society
    https://cancer.ca/en/cancer-information/cancer-types/lung/treatment/radiation-therapy
    The following types of radiation therapy are most commonly used to treat lung cancer. […] External radiation therapy is usually given 5 days a week, for 5 to 7 weeks. If it is being used as a palliative therapy, it may not be given for as long. […] SBRT for lung cancer is given over 7 to 10 days, which is much shorter than other ways of giving radiation therapy. […] Prophylactic cranial irradiation (PCI) is external beam radiation given to the whole brain. It is used to prevent small cell lung cancer from spreading to the brain or to treat cancer cells that may have already spread there but cannot be seen by imaging tests. It may help prevent brain metastases and improve survival. […] Brachytherapy may be used to treat a tumour that is blocking an airway of the lung. It may also be used as a primary treatment if you cannot have external radiation therapy because of poor lung function.
  • #25 6 Innovative Lung Cancer Treatment Options | MD Anderson Cancer Center
    https://www.mdanderson.org/cancer-types/lung-cancer/lung-cancer-treatment.html
    Sleeve lobectomy: A more complex form of lobectomy that is typically used for centrally located tumors. […] Pneumonectomy: Removal of an entire lung. This surgery is occasionally required due to the location of the tumor. […] Treatment following surgery is called adjuvant therapy. […] Radiation therapy uses focused, high-energy photon beams to destroy lung cancer cells. […] The radiation therapy treatments used for lung cancer patients include: 3D-conformal radiation therapy: Several radiation beams are given in the exact shape of the tumor. […] Intensity-modulate radiotherapy (IMRT): Treatment is tailored to the specific shape of the tumor. […] Stereotactic body radiation therapy (SBRT): High doses of radiation delivered with several beams at various intensities and angles to precisely target the tumor.
  • #26 Radiation therapy for lung cancer | Canadian Cancer Society
    https://cancer.ca/en/cancer-information/cancer-types/lung/treatment/radiation-therapy
    The following types of radiation therapy are most commonly used to treat lung cancer. […] External radiation therapy is usually given 5 days a week, for 5 to 7 weeks. If it is being used as a palliative therapy, it may not be given for as long. […] SBRT for lung cancer is given over 7 to 10 days, which is much shorter than other ways of giving radiation therapy. […] Prophylactic cranial irradiation (PCI) is external beam radiation given to the whole brain. It is used to prevent small cell lung cancer from spreading to the brain or to treat cancer cells that may have already spread there but cannot be seen by imaging tests. It may help prevent brain metastases and improve survival. […] Brachytherapy may be used to treat a tumour that is blocking an airway of the lung. It may also be used as a primary treatment if you cannot have external radiation therapy because of poor lung function.
  • #27 Radiation therapy for lung cancer | Canadian Cancer Society
    https://cancer.ca/en/cancer-information/cancer-types/lung/treatment/radiation-therapy
    Side effects of radiation therapy used for lung cancer are: fatigue, difficulty breathing, including a cough and shortness of breath, nausea and vomiting, sore throat, difficulty swallowing, loss of appetite, radiation pneumonitis, skin problems, heart problems if the treatment area is near the heart, scarring of the lung tissues (pulmonary fibrosis).
  • #28 Lung Cancer Treatment
    https://www.radiologyinfo.org/en/info/lung-cancer-therapy
    When cure is not a possibility, doctors recommend palliative treatment. […] Pain relief is a very important part of treating lung cancer. […] Radiation therapy delivers focused high-energy x-rays (photons), gamma rays, or atomic particles. […] Overall, radiotherapy is a local treatment. […] Most patients tire easily during their course of radiation treatment. […] Skin irritation is common after a few weeks of radiation therapy. […] An inflammation of the lungs called radiation pneumonitis may develop three to six months after radiotherapy is over. […] Once radiotherapy ends, your doctor will want to see you after four to six weeks and then every three to six months for the first two years. […] Any lung cancer patient should consider taking part in a clinical trial to help find more effective treatments for lung cancer. […] Less invasive surgical methods are under study. […] Angiogenesis inhibitors are agents that prevent new blood vessels from forming in growing cancers and may shut off the tumor’s blood supply.
  • #29 Lung cancer – Diagnosis and treatment – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/lung-cancer/diagnosis-treatment/drc-20374627
    Chemotherapy treats cancer with strong medicines. Many chemotherapy medicines exist. Most are given through a vein. Some come in pill form. A combination of medicines usually is given in a series of treatments over a period of weeks or months. Breaks in between are used to help you recover. […] Chemotherapy is often used after surgery to kill any cancer cells that may remain. It can be used alone or combined with radiation therapy. Chemotherapy also may be used before surgery to shrink cancers and make them easier to remove. […] For lung cancers that have spread to other areas of the body, radiation therapy may help relieve symptoms. […] Targeted therapy for cancer is a treatment that uses medicines that attack specific chemicals in the cancer cells. By blocking these chemicals, targeted treatments can cause cancer cells to die. For lung cancer, targeted therapy may be used for people with cancer that spreads or comes back after treatment.
  • #30 Lung Cancer: Types, Stages, Symptoms, Diagnosis & Treatment
    https://my.clevelandclinic.org/health/diseases/4375-lung-cancer
    Lung cancer is the third most common cancer in the U.S. Treatments include surgery, chemotherapy, immunotherapy, radiation and targeted drugs. Advances in treatments have caused a significant decline in lung cancer deaths in recent years. […] Lung cancer treatments include surgery, radiofrequency ablation, radiation therapy, chemotherapy, targeted drug therapy and immunotherapy. […] NSCLC that hasnt spread and SCLC thats limited to a single tumor can be eligible for surgery. Your surgeon might remove the tumor and a small amount of healthy tissue around it to make sure they dont leave any cancer cells behind. […] Radiation uses high energy beams to kill cancer cells. It can be used by itself or to help make surgery more effective. […] Chemotherapy is often a combination of multiple medications designed to stop cancer cells from growing.
  • #31 Lung cancer – Diagnosis and treatment – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/lung-cancer/diagnosis-treatment/drc-20374627
    Chemotherapy treats cancer with strong medicines. Many chemotherapy medicines exist. Most are given through a vein. Some come in pill form. A combination of medicines usually is given in a series of treatments over a period of weeks or months. Breaks in between are used to help you recover. […] Chemotherapy is often used after surgery to kill any cancer cells that may remain. It can be used alone or combined with radiation therapy. Chemotherapy also may be used before surgery to shrink cancers and make them easier to remove. […] For lung cancers that have spread to other areas of the body, radiation therapy may help relieve symptoms. […] Targeted therapy for cancer is a treatment that uses medicines that attack specific chemicals in the cancer cells. By blocking these chemicals, targeted treatments can cause cancer cells to die. For lung cancer, targeted therapy may be used for people with cancer that spreads or comes back after treatment.
  • #32 Lung cancer – Diagnosis and treatment – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/lung-cancer/diagnosis-treatment/drc-20374627
    Chemotherapy treats cancer with strong medicines. Many chemotherapy medicines exist. Most are given through a vein. Some come in pill form. A combination of medicines usually is given in a series of treatments over a period of weeks or months. Breaks in between are used to help you recover. […] Chemotherapy is often used after surgery to kill any cancer cells that may remain. It can be used alone or combined with radiation therapy. Chemotherapy also may be used before surgery to shrink cancers and make them easier to remove. […] For lung cancers that have spread to other areas of the body, radiation therapy may help relieve symptoms. […] Targeted therapy for cancer is a treatment that uses medicines that attack specific chemicals in the cancer cells. By blocking these chemicals, targeted treatments can cause cancer cells to die. For lung cancer, targeted therapy may be used for people with cancer that spreads or comes back after treatment.
  • #33 Non-small Cell Lung Cancer Treatment by Stage | American Cancer Society
    https://www.cancer.org/cancer/types/lung-cancer/treating-non-small-cell/by-stage.html
    For people with stage I NSCLC that has a higher risk of coming back (based on size, location, or other factors), chemotherapy, immunotherapy, and possibly targeted therapy (ie. alectinib, osimertinib) after surgery may lower the risk that cancer will return. This is called adjuvant treatment. […] Neoadjuvant (pre-operative) chemotherapy with or without immunotherapy is usually offered to patients with stage II NSCLC. […] The initial treatment for stage IIIA NSCLC may include some combination of radiation therapy, chemotherapy (chemo), immunotherapy, and/or surgery. […] Stage IIIB NSCLC has spread to lymph nodes that are near the other lung or in the neck, and may also have grown into important structures in the chest. These cancers cant be removed completely by surgery. […] Stage IVA or IVB NSCLC has already spread when it is diagnosed. These cancers can be very hard to cure. Treatment options depend on where and how far the cancer has spread, whether the cancer cells have certain gene or protein changes, and your overall health. […] If cancer continues to grow during treatment (progresses) or comes back (recurs), further treatment will depend on the location and extent of the cancer, what treatments have been used, and on the persons health and desire for more treatment.
  • #34 Treatments for stage 4 non–small cell lung cancer | Canadian Cancer Society
    https://cancer.ca/en/cancer-information/cancer-types/lung/treatment/stage-4
    Immunotherapy may be offered for stage 4 nonsmall cell lung cancer. […] Pembrolizumab (Keytruda) may be used to treat nonsmall cell lung cancer that make too much PD-1. […] External beam radiation therapy may be used for stage 4 nonsmall cell lung cancer if you can’t have chemotherapy. It is also used to relieve symptoms caused by the cancer (palliative radiation therapy). […] Surgery may be used to treat stage 4 nonsmall cell lung cancer that has spread to the adrenal gland, brain or liver.
  • #35 Lung Cancer Chemotherapy
    https://www.froedtert.com/lung-cancer/treatment/chemotherapy
    Chemotherapy is the treatment backbone for a significant number of lung cancer patients. […] The standard treatment approach for small cell lung cancer that has not spread is chemotherapy and radiation given at the same time. […] More advanced stages are generally treated with chemotherapy first and may be followed by radiation therapy to the chest, the brain, and other sites of disease depending on the response to chemotherapy and symptoms. […] Currently, 10 – 12 chemotherapy drugs are recommended for treating non-small cell lung cancer. […] The best chance for a cure for thoracic mesothelioma is through a combination of surgery, chemotherapy and radiation therapy. […] If lung cancer is confined to the lung (Stage I) and surgically removed, chemotherapy is sometimes given to prevent recurrence. This is considered curative chemotherapy.
  • #36 Lung Cancer Chemotherapy
    https://www.froedtert.com/lung-cancer/treatment/chemotherapy
    Chemotherapy is the treatment backbone for a significant number of lung cancer patients. […] The standard treatment approach for small cell lung cancer that has not spread is chemotherapy and radiation given at the same time. […] More advanced stages are generally treated with chemotherapy first and may be followed by radiation therapy to the chest, the brain, and other sites of disease depending on the response to chemotherapy and symptoms. […] Currently, 10 – 12 chemotherapy drugs are recommended for treating non-small cell lung cancer. […] The best chance for a cure for thoracic mesothelioma is through a combination of surgery, chemotherapy and radiation therapy. […] If lung cancer is confined to the lung (Stage I) and surgically removed, chemotherapy is sometimes given to prevent recurrence. This is considered curative chemotherapy.
  • #37 Small Cell Lung Cancer Treatment (PDQ®) – PDQ Cancer Information Summaries – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/books/NBK65909/
    The combination of platinum and etoposide is the most widely used standard chemotherapeutic regimen. […] SCLC is highly radiosensitive and thoracic radiation therapy improves survival of patients with LD and ED tumors. […] Prophylactic cranial irradiation prevents central nervous system recurrence and may improve the long-term survival of patients with good performance status who have responded to chemoradiation therapy. […] Combined-modality treatment with etoposide and cisplatin with thoracic radiation therapy (TRT) is the most widely used treatment for patients with limited-stage disease (LD) SCLC. […] Patients with LD have improved long-term survival with combined-modality therapy. […] Patients diagnosed with LD who smoke should be encouraged to stop smoking before undergoing combined-modality therapy because continued smoking may compromise survival.
  • #38 Treatments for stage 4 non–small cell lung cancer | Canadian Cancer Society
    https://cancer.ca/en/cancer-information/cancer-types/lung/treatment/stage-4
    The following are treatment options for stage 4 nonsmall cell lung cancer. Your healthcare team will suggest treatments based on your needs and work with you to develop a treatment plan. […] Chemotherapy may be offered for stage 4 nonsmall cell lung cancer if there are no genetic changes (mutations) that can be identified in the lung cancer tumours using cell and tissue studies. You need to be well enough to have chemotherapy. […] The most common chemotherapy drug combination used to treat stage 4 nonsmall cell lung cancer is cisplatin or carboplatin with gemcitabine. Other chemotherapy combinations that may be used include: cisplatin or carboplatin and docetaxel (Taxotere), carboplatin and paclitaxel, gemcitabine and docetaxel, gemcitabine and vinorelbine, cisplatin and pemetrexed (Alimta) only used for non-squamous types of nonsmall cell lung cancer.
  • #39 Treatments for stage 4 non–small cell lung cancer | Canadian Cancer Society
    https://cancer.ca/en/cancer-information/cancer-types/lung/treatment/stage-4
    Pemetrexed may also be offered by itself as maintenance therapy to slow the return of lung cancer if the cancer has responded to chemotherapy. You will not be offered pemetrexed if you have already had it as part of your chemotherapy treatment. […] Targeted therapy may be offered instead of chemotherapy for stage 4 nonsmall cell lung cancer if there are genetic changes to the lung cancer cells. The type of targeted therapy given will depend on the type of genetic mutation that was identified using cell and tissue studies. […] EGFR-positive stage 4 nonsmall cell lung cancer may be treated with erlotinib (Tarceva), gefitinib (Iressa) or osimertinib (Tagrisso) instead of chemotherapy. […] Stage 4 nonsmall cell lung cancer that is BRAF V600E positive may be treated with a combination of dabrafenib (Tafinlar) and trametinib (Mekinist).
  • #40 Small Cell Lung Cancer Treatment (PDQ®) – PDQ Cancer Information Summaries – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/books/NBK65909/
    The combination of platinum and etoposide is the most widely used standard chemotherapeutic regimen. […] SCLC is highly radiosensitive and thoracic radiation therapy improves survival of patients with LD and ED tumors. […] Prophylactic cranial irradiation prevents central nervous system recurrence and may improve the long-term survival of patients with good performance status who have responded to chemoradiation therapy. […] Combined-modality treatment with etoposide and cisplatin with thoracic radiation therapy (TRT) is the most widely used treatment for patients with limited-stage disease (LD) SCLC. […] Patients with LD have improved long-term survival with combined-modality therapy. […] Patients diagnosed with LD who smoke should be encouraged to stop smoking before undergoing combined-modality therapy because continued smoking may compromise survival.
  • #41 Patient education: Small cell lung cancer treatment (Beyond the Basics) – UpToDate
    https://www.uptodate.com/contents/small-cell-lung-cancer-treatment-beyond-the-basics/print
    Patients with extensive-stage small cell lung cancer are generally treated with chemotherapy and immunotherapy; surgery is not an option. Extensive-stage disease is not considered to be curable, and the goals of treatment are to relieve symptoms caused by the cancer and to prolong life. […] Systemic therapy refers to medicines that go throughout the body to kill cancer cells wherever they might be. For small cell lung cancer, systemic therapy generally consists of chemotherapy with or without immunotherapy. Chemotherapy refers to the use of medicines to either kill cancer cells or stop their growth. It is the mainstay of treatment for small cell lung cancer. […] The optimal duration of initial chemotherapy or chemotherapy plus immunotherapy for people with small cell lung cancer is determined by how the cancer is responding to treatment, and how the patient’s body tolerates the treatment. Typically, four to six cycles of initial chemotherapy with or without immunotherapy are recommended.
  • #42 Treatments for stage 4 non–small cell lung cancer | Canadian Cancer Society
    https://cancer.ca/en/cancer-information/cancer-types/lung/treatment/stage-4
    Pemetrexed may also be offered by itself as maintenance therapy to slow the return of lung cancer if the cancer has responded to chemotherapy. You will not be offered pemetrexed if you have already had it as part of your chemotherapy treatment. […] Targeted therapy may be offered instead of chemotherapy for stage 4 nonsmall cell lung cancer if there are genetic changes to the lung cancer cells. The type of targeted therapy given will depend on the type of genetic mutation that was identified using cell and tissue studies. […] EGFR-positive stage 4 nonsmall cell lung cancer may be treated with erlotinib (Tarceva), gefitinib (Iressa) or osimertinib (Tagrisso) instead of chemotherapy. […] Stage 4 nonsmall cell lung cancer that is BRAF V600E positive may be treated with a combination of dabrafenib (Tafinlar) and trametinib (Mekinist).
  • #43 Treatment Options for Lung Cancer | LUNGevity Foundation
    https://www.lungevity.org/for-patients-caregivers/navigating-your-diagnosis/treatment-options-for-lung-cancer
    Surgery is a treatment that removes a cancerous tumor during an operation. Its most often used when lung cancer is caught early. […] Radiation therapy (also known as radiotherapy) uses high-powered energy beams to kill cancer cells and shrink tumors. The goal is to target the cancerous portions while avoiding healthy tissue. […] Chemotherapy uses drugs to stop the growth of cancerous cells and is a widely used treatment across all stages and types of lung cancer. […] Targeted therapy drugs focus on and attack specific parts of cancer cells that are driving cancer growth, while causing less harm to normal cells. […] Immunotherapy is a treatment strategy that enhances the body’s natural immune system instead of directly targeting cancer cells. The goal is for the immune system to be strong enough to fight cancer cells.
  • #44 Lung Cancer: Types, Stages, Symptoms, Diagnosis & Treatment
    https://my.clevelandclinic.org/health/diseases/4375-lung-cancer
    In some people with NSCLC, lung cancer cells have specific changes (mutations) that help the cancer grow. Special drugs target these mutations to try to slow down or destroy cancer cells. […] Immunotherapy reveals cancer cells to your immune system so your own body can fight cancer. […] Some lung cancer treatments are used to relieve symptoms, like pain and difficulty breathing. […] Side effects of lung cancer treatment depend on the type of treatment. […] Your provider can prescribe medications to help manage your symptoms or side effects of treatment.
  • #45 Treatments for stage 4 non–small cell lung cancer | Canadian Cancer Society
    https://cancer.ca/en/cancer-information/cancer-types/lung/treatment/stage-4
    Pemetrexed may also be offered by itself as maintenance therapy to slow the return of lung cancer if the cancer has responded to chemotherapy. You will not be offered pemetrexed if you have already had it as part of your chemotherapy treatment. […] Targeted therapy may be offered instead of chemotherapy for stage 4 nonsmall cell lung cancer if there are genetic changes to the lung cancer cells. The type of targeted therapy given will depend on the type of genetic mutation that was identified using cell and tissue studies. […] EGFR-positive stage 4 nonsmall cell lung cancer may be treated with erlotinib (Tarceva), gefitinib (Iressa) or osimertinib (Tagrisso) instead of chemotherapy. […] Stage 4 nonsmall cell lung cancer that is BRAF V600E positive may be treated with a combination of dabrafenib (Tafinlar) and trametinib (Mekinist).
  • #46 Treatments for stage 4 non–small cell lung cancer | Canadian Cancer Society
    https://cancer.ca/en/cancer-information/cancer-types/lung/treatment/stage-4
    Pemetrexed may also be offered by itself as maintenance therapy to slow the return of lung cancer if the cancer has responded to chemotherapy. You will not be offered pemetrexed if you have already had it as part of your chemotherapy treatment. […] Targeted therapy may be offered instead of chemotherapy for stage 4 nonsmall cell lung cancer if there are genetic changes to the lung cancer cells. The type of targeted therapy given will depend on the type of genetic mutation that was identified using cell and tissue studies. […] EGFR-positive stage 4 nonsmall cell lung cancer may be treated with erlotinib (Tarceva), gefitinib (Iressa) or osimertinib (Tagrisso) instead of chemotherapy. […] Stage 4 nonsmall cell lung cancer that is BRAF V600E positive may be treated with a combination of dabrafenib (Tafinlar) and trametinib (Mekinist).
  • #47 New Lung Cancer Treatments Aim to Reduce Deaths in 2025 and Beyond | Memorial Sloan Kettering Cancer Center
    https://www.mskcc.org/news/new-lung-cancer-treatments-aim-to-reduce-deaths-in-2025-and-beyond
    We perform comprehensive genetic testing of tumors in all patients with non-small cell lung cancer. This is now a routine part of diagnosis and staging for every MSK patient with NSCLC. […] We are getting new targeted therapies approved every year for genes that were long thought to be undruggable. […] Our goal for people with metastatic lung cancer is to help them live much longer, with a much higher quality of life that isnt disrupted by the cancer therapy. […] Several forms of immunotherapy to treat lung cancer have become the standard of care or are being tested in clinical trials. […] In addition to checkpoint inhibitors, a new immunotherapy drug called tarlatamab (Imdelltra) was recently approved for SCLC. It targets a protein on cancer cells called DLL3. […] The best way to improve the prognosis for lung cancer is early detection. […] Overall, its an exciting time, and weve seen tremendous progress in the treatment of lung cancer.
  • #48 Lung Cancer – UChicago Medicine
    https://www.uchicagomedicine.org/cancer/types-treatments/lung-cancer
    Thoracic surgeon Jessica Donington, MD, is an expert in minimally invasive and robotic lung cancer surgery and serves as Chief of the Section of Thoracic Surgery. […] Most patients with lung cancer need more than one type of therapy as part of their care plan. Patients at the University of Chicago Medicine have access to a full range of treatment options, including surgery, radiation therapy and chemotherapy, well as clinical trials of the newest targeted treatments, including immunotherapies. […] Our molecular pathology lab searches across more than 1,000 genes to screen for these mutations for every patient with lung cancer. Therapy can then be matched, or targeted to, the specific genetic changes in each tumor. […] UChicago Medicine lung cancer surgeons are board-certified thoracic surgeons who focus on treating diseases only of the lung and chest. They perform surgery using minimally invasive techniques, which results in smaller scars, less pain and fewer complications after surgery as compared to traditional open procedures.
  • #49 Lung Cancer: Types, Stages, Symptoms, Diagnosis & Treatment
    https://my.clevelandclinic.org/health/diseases/4375-lung-cancer
    In some people with NSCLC, lung cancer cells have specific changes (mutations) that help the cancer grow. Special drugs target these mutations to try to slow down or destroy cancer cells. […] Immunotherapy reveals cancer cells to your immune system so your own body can fight cancer. […] Some lung cancer treatments are used to relieve symptoms, like pain and difficulty breathing. […] Side effects of lung cancer treatment depend on the type of treatment. […] Your provider can prescribe medications to help manage your symptoms or side effects of treatment.
  • #50 Immunotherapy for Lung Cancer – Cancer Research Institute
    https://www.cancerresearch.org/cancer-types/lung-cancer
    Immunotherapy for lung cancer, alone or in combination with conventional treatments, can significantly improve outcomes for patients fighting lung cancer. […] New treatments are needed for patients facing an advanced lung cancer diagnosis. Fortunately, immune-based cancer treatments are helping to improve chances of living longer for patients with lung cancer. […] Until recently, conventional treatment options for lung cancer included surgery, chemotherapy, and radiation. Since the majority of lung cancer patients are diagnosed with advanced disease (stage 3b/4), these treatments are unlikely to result in complete cures, though they may significantly improve survival and provide symptom relief. […] In 2015, the U.S. FDA approved the first immunotherapy to treat a subset of lung cancer patients. Immunotherapy is a class of treatments that helps a person’s own immune system eliminate or control cancer. Recent clinical studies treating patients with immunotherapy, either alone or in combination with other treatments, have demonstrated significant patient improvement, resulting in FDA approval of several other immunotherapy options for more lung cancer patients, including approvals to treat patients with immunotherapy as a first-line therapy instead of conventional treatments.
  • #51 Immunotherapy for Lung Cancer – Cancer Research Institute
    https://www.cancerresearch.org/cancer-types/lung-cancer
    These checkpoint immunotherapy approvals were landmark events for the treatment of lung cancer. With these immunotherapies, many advanced-stage lung cancer patients are starting to see long-lasting remissions and longer survival rates. Several immunotherapy agents are currently being tested in lung cancer clinical trials. […] CRI-funded discoveries and breakthroughs, along with ongoing studies, include: The benefits of anti-PD-1 checkpoint immunotherapy prior to surgery in patients with advanced lung cancer, highlighted in a recent study led by members of the CRI-SU2C Dream Team. […] Immunomodulators manipulate the “brakes” and “gas pedals” of the immune system. Checkpoint inhibitors target molecules on immune cells to unleash new or enhance existing immune responses against cancer. […] Oncolytic virus therapy uses viruses that are often, but not always, modified in order to infect tumor cells and cause them to self-destruct. This can attract the attention of immune cells to eliminate the main tumor and potentially other tumors throughout the body.
  • #52 Immunotherapy for Lung Cancer: Types, Side Effects & More
    https://www.cancercenter.com/cancer-types/lung-cancer/treatments/immunotherapy
    Your immune system cells detect and fight infections throughout the body. Immunotherapy drugs help the immune system find and attack any cancer cells that may be evading detection. […] Immunotherapy drugs for lung cancer focus on the way cancer cells and your immune system cells communicate via the proteins on their surfaces. Some immunotherapy drugs disrupt the receptors on immune cells, making them more sensitive to foreign substances like cancer cells and more responsive so they can fight them. Other drugs disrupt the proteins on the cancer cell surface, making it harder for these to hide from your immune system. […] Most lung cancer immunotherapy drugs approved by the U.S. Food and Drug Administration (FDA) work by disrupting the interaction between the PD-L1 protein on cancer cells and the PD-1 receptor on immune T-cells. Another immunotherapy drug disrupts the CTLA-4 protein on immune T-cells. When these connections are broken, T-cells are better able to recognize cancer cells and respond to them.
  • #53 Immunotherapy for Lung Cancer: Types, Side Effects & More
    https://www.cancercenter.com/cancer-types/lung-cancer/treatments/immunotherapy
    The following immunotherapy drugs can be used for NSCLC: Tecentriq, Libtayo, Imfinzi, Yervoy, Opdivo, Keytruda. […] The following immunotherapy drugs are used for small cell lung cancer (SCLC): Tecentriq, Imfinzi, Opdivo, Keytruda. […] Your care team will administer your immunotherapy drugs through an intravenous (IV) line into your vein, typically at an outpatient clinic. This is called an infusion or, more specifically, an immunotherapy infusion. […] In cases of advanced SCLC, the checkpoint inhibitors Tecentriq and Imfinzi can be used along with certain chemotherapy drugs as an initial treatment and they may be continued after chemotherapy as a maintenance treatment. […] For advanced NSCLC patients, Keytruda, Tecentriq or Libtayo can sometimes be paired with chemotherapy as an initial treatment.
  • #54 Immunotherapy for Lung Cancer: Types, Side Effects & More
    https://www.cancercenter.com/cancer-types/lung-cancer/treatments/immunotherapy
    Researchers have been studying the effect of immunotherapy after other therapies called adjuvant immunotherapy for NSCLC. […] Immunotherapy drugs tend to have less serious side effects than chemotherapy, but they can still affect how you feel. […] Side effects from immunotherapy drugs may include fatigue, skin rash, itching, gastrointestinal issues such as constipation and diarrhea, nausea, cough, loss of appetite, joint pain. […] Some people may have an infusion reaction during immunotherapy, which is similar to an allergic reaction. […] Its also possible for your immune system to start attacking other parts of your body due to immunotherapy, not just cancer cells. […] Many clinical trials are underway to identify new ways of using immunotherapy to treat lung cancer, and recent breakthroughs have improved the success of immunotherapy treatments.
  • #55 Treatments for Small Cell Lung Cancer: What’s new | LCFA
    https://lcfamerica.org/treatment/small-cell-lung-cancer-sclc/
    The immunotherapy drugs atezolizumab and durvalumab block the protein PD-L1 and boost the bodys immune response to cancer cells. When used in combination with chemotherapy, these drugs increased overall survival (OS) and progression-free survival (PFS) from chemotherapy alone. […] In February of 2021, the FDA approved the drug trilaciclib (Coasela) for patients with extensive-stage SCLC undergoing chemotherapy. Trilaciclib limits the damage chemotherapy causes to bone marrow, called myelosuppression. This treatment makes patients less susceptible to fatigue and infection and less likely to need rescue interventions during treatment. They are more likely to finish their treatment on schedule. […] In 2020, the FDA approved the new chemotherapy drug lurbinectedin (Zepzelca) to treat metastatic SCLC that has progressed on or after platinum-based chemotherapy. Lubinectedin works by selectively blocking oncogenic transcription, or the process by which tumor cells reproduce. It interferes with the tumor cells reproduction cycle and causes cell death.
  • #56 Patient education: Small cell lung cancer treatment (Beyond the Basics) – UpToDate
    https://www.uptodate.com/contents/small-cell-lung-cancer-treatment-beyond-the-basics/print
    The most commonly used combination of chemotherapy drugs for patients with limited-stage small cell lung cancer is cisplatin plus etoposide. […] An immunotherapy drug, either atezolizumab or durvalumab, is usually added to chemotherapy for people with extensive-stage disease. The addition of immunotherapy to chemotherapy has been shown to prolong duration of treatment response and survival. […] Chemotherapy is of clear benefit in patients with small cell lung cancer, improving both quality of life and duration of survival. […] The goal of treatment for people with limited-stage small cell lung cancer is cure, which is achieved in 30 to 35 percent of patients. […] Extensive-stage small cell lung cancer is not considered to be a curable disease. The goals of therapy are to relieve symptoms, maintain quality of life, and prolong patient survival.
  • #57 Treatments for Small Cell Lung Cancer: What’s new | LCFA
    https://lcfamerica.org/treatment/small-cell-lung-cancer-sclc/
    On May 16, 2024, the Food and Drug Administration granted accelerated approval to tarlatamab-dlle (Imdelltra, Amgen, Inc.) for extensive stage small cell lung cancer (ES-SCLC) with disease progression on or after platinum-based chemotherapy. […] This injectable medicine is an antibody that targets a protein on cancer cells called DLL3. By attaching to DLL3, tarlatamab helps the bodys immune system find and destroy the cancer cells. In a clinical trial, some patients who received tarlatamab had their tumors shrink or disappear for some time. […] Beginning in 2019, immunotherapy was added as part of the first-line treatment for extensive-stage small cell lung cancer. Immunotherapies can prolong the bodys response to conventional chemotherapy and offers a promising addition to SCLC treatment.
  • #58 Immunotherapy for Lung Cancer: Types, Side Effects & More
    https://www.cancercenter.com/cancer-types/lung-cancer/treatments/immunotherapy
    Researchers have been studying the effect of immunotherapy after other therapies called adjuvant immunotherapy for NSCLC. […] Immunotherapy drugs tend to have less serious side effects than chemotherapy, but they can still affect how you feel. […] Side effects from immunotherapy drugs may include fatigue, skin rash, itching, gastrointestinal issues such as constipation and diarrhea, nausea, cough, loss of appetite, joint pain. […] Some people may have an infusion reaction during immunotherapy, which is similar to an allergic reaction. […] Its also possible for your immune system to start attacking other parts of your body due to immunotherapy, not just cancer cells. […] Many clinical trials are underway to identify new ways of using immunotherapy to treat lung cancer, and recent breakthroughs have improved the success of immunotherapy treatments.
  • #59 Lung cancer – Diagnosis and treatment – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/lung-cancer/diagnosis-treatment/drc-20374627
    If you have surgery, your surgeon also may remove lymph nodes from your chest to test them for cancer. […] Surgery may be an option if your cancer is only in the lungs. If you have a larger lung cancer, chemotherapy or radiation therapy may be used before surgery to shrink the cancer. Chemotherapy or radiation therapy also may be used after surgery if there’s a risk that cancer cells were left behind or that your cancer may come back. […] Radiation therapy treats cancer with powerful energy beams. The energy can come from X-rays, protons or other sources. During radiation therapy, you lie on a table while a machine moves around you. The machine directs radiation to precise points on your body. […] For lung cancer that has spread within the chest, radiation may be used before surgery or after surgery. It’s often combined with chemotherapy treatments. If surgery isn’t an option, combined chemotherapy and radiation therapy may be your first treatment.
  • #60 Lung cancer treatment – types and what to expect | Macmillan Cancer Support
    https://www.macmillan.org.uk/cancer-information-and-support/lung-cancer/treatment-for-lung-cancer
    Treatments for lung cancer include surgery, chemotherapy, radiotherapy, immunotherapy and targeted therapy. […] Treatment for lung cancer can include: surgery, chemotherapy, radiotherapy, targeted and immunotherapy drugs. […] You may have a combination of treatments. Sometimes people have different treatments one after the other to help to keep the cancer under control. […] The treatment you have will depend on: the stage of the cancer, the type of lung cancer you have small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC) are treated in different ways, your general health. […] Newer treatments are being developed. Your cancer doctor may talk to you about having treatment as part of a clinical trial. […] If you have non-small cell lung cancer (NSCLC), it may be possible to remove the cancer with surgery.
  • #61 Radiation therapy for lung cancer | Canadian Cancer Society
    https://cancer.ca/en/cancer-information/cancer-types/lung/treatment/radiation-therapy
    Radiation therapy uses high-energy rays or particles to destroy cancer cells. Most people with lung cancer have radiation therapy. Your healthcare team will consider your personal needs to plan the type and amount of radiation, and when and how it is given. You may also receive other treatments. […] Radiation therapy is often combined with chemotherapy to treat lung cancer. This is called chemoradiation. The 2 treatments are given during the same time period. You will not be offered chemoradiation if you aren’t healthy enough to have this type of treatment. […] Radiation therapy is given for different reasons. You may have radiation therapy or chemoradiation: as the main treatment for lung cancer that can’t be removed with surgery, or if you don’t want to have surgery; after surgery to lower the risk of the cancer coming back (recurring) (called adjuvant therapy); to relieve pain or control the symptoms of advanced lung cancer (called palliative therapy); to treat lung cancer that has spread to the brain (brain metastases); to prevent small cell lung cancer from spreading in the brain.
  • #62 Small Cell Lung Cancer Treatment (PDQ®) – PDQ Cancer Information Summaries – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/books/NBK65909/
    The combination of platinum and etoposide is the most widely used standard chemotherapeutic regimen. […] SCLC is highly radiosensitive and thoracic radiation therapy improves survival of patients with LD and ED tumors. […] Prophylactic cranial irradiation prevents central nervous system recurrence and may improve the long-term survival of patients with good performance status who have responded to chemoradiation therapy. […] Combined-modality treatment with etoposide and cisplatin with thoracic radiation therapy (TRT) is the most widely used treatment for patients with limited-stage disease (LD) SCLC. […] Patients with LD have improved long-term survival with combined-modality therapy. […] Patients diagnosed with LD who smoke should be encouraged to stop smoking before undergoing combined-modality therapy because continued smoking may compromise survival.
  • #63 Lung cancer – Diagnosis and treatment – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/lung-cancer/diagnosis-treatment/drc-20374627
    If you have surgery, your surgeon also may remove lymph nodes from your chest to test them for cancer. […] Surgery may be an option if your cancer is only in the lungs. If you have a larger lung cancer, chemotherapy or radiation therapy may be used before surgery to shrink the cancer. Chemotherapy or radiation therapy also may be used after surgery if there’s a risk that cancer cells were left behind or that your cancer may come back. […] Radiation therapy treats cancer with powerful energy beams. The energy can come from X-rays, protons or other sources. During radiation therapy, you lie on a table while a machine moves around you. The machine directs radiation to precise points on your body. […] For lung cancer that has spread within the chest, radiation may be used before surgery or after surgery. It’s often combined with chemotherapy treatments. If surgery isn’t an option, combined chemotherapy and radiation therapy may be your first treatment.
  • #64 Non-small Cell Lung Cancer Treatment by Stage | American Cancer Society
    https://www.cancer.org/cancer/types/lung-cancer/treating-non-small-cell/by-stage.html
    For people with stage I NSCLC that has a higher risk of coming back (based on size, location, or other factors), chemotherapy, immunotherapy, and possibly targeted therapy (ie. alectinib, osimertinib) after surgery may lower the risk that cancer will return. This is called adjuvant treatment. […] Neoadjuvant (pre-operative) chemotherapy with or without immunotherapy is usually offered to patients with stage II NSCLC. […] The initial treatment for stage IIIA NSCLC may include some combination of radiation therapy, chemotherapy (chemo), immunotherapy, and/or surgery. […] Stage IIIB NSCLC has spread to lymph nodes that are near the other lung or in the neck, and may also have grown into important structures in the chest. These cancers cant be removed completely by surgery. […] Stage IVA or IVB NSCLC has already spread when it is diagnosed. These cancers can be very hard to cure. Treatment options depend on where and how far the cancer has spread, whether the cancer cells have certain gene or protein changes, and your overall health. […] If cancer continues to grow during treatment (progresses) or comes back (recurs), further treatment will depend on the location and extent of the cancer, what treatments have been used, and on the persons health and desire for more treatment.
  • #65 Lung cancer – Diagnosis and treatment – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/lung-cancer/diagnosis-treatment/drc-20374627
    If you have surgery, your surgeon also may remove lymph nodes from your chest to test them for cancer. […] Surgery may be an option if your cancer is only in the lungs. If you have a larger lung cancer, chemotherapy or radiation therapy may be used before surgery to shrink the cancer. Chemotherapy or radiation therapy also may be used after surgery if there’s a risk that cancer cells were left behind or that your cancer may come back. […] Radiation therapy treats cancer with powerful energy beams. The energy can come from X-rays, protons or other sources. During radiation therapy, you lie on a table while a machine moves around you. The machine directs radiation to precise points on your body. […] For lung cancer that has spread within the chest, radiation may be used before surgery or after surgery. It’s often combined with chemotherapy treatments. If surgery isn’t an option, combined chemotherapy and radiation therapy may be your first treatment.
  • #66 Non-small Cell Lung Cancer Treatment by Stage | American Cancer Society
    https://www.cancer.org/cancer/types/lung-cancer/treating-non-small-cell/by-stage.html
    For people with stage I NSCLC that has a higher risk of coming back (based on size, location, or other factors), chemotherapy, immunotherapy, and possibly targeted therapy (ie. alectinib, osimertinib) after surgery may lower the risk that cancer will return. This is called adjuvant treatment. […] Neoadjuvant (pre-operative) chemotherapy with or without immunotherapy is usually offered to patients with stage II NSCLC. […] The initial treatment for stage IIIA NSCLC may include some combination of radiation therapy, chemotherapy (chemo), immunotherapy, and/or surgery. […] Stage IIIB NSCLC has spread to lymph nodes that are near the other lung or in the neck, and may also have grown into important structures in the chest. These cancers cant be removed completely by surgery. […] Stage IVA or IVB NSCLC has already spread when it is diagnosed. These cancers can be very hard to cure. Treatment options depend on where and how far the cancer has spread, whether the cancer cells have certain gene or protein changes, and your overall health. […] If cancer continues to grow during treatment (progresses) or comes back (recurs), further treatment will depend on the location and extent of the cancer, what treatments have been used, and on the persons health and desire for more treatment.
  • #67 Immunotherapy for Lung Cancer: Types, Side Effects & More
    https://www.cancercenter.com/cancer-types/lung-cancer/treatments/immunotherapy
    The following immunotherapy drugs can be used for NSCLC: Tecentriq, Libtayo, Imfinzi, Yervoy, Opdivo, Keytruda. […] The following immunotherapy drugs are used for small cell lung cancer (SCLC): Tecentriq, Imfinzi, Opdivo, Keytruda. […] Your care team will administer your immunotherapy drugs through an intravenous (IV) line into your vein, typically at an outpatient clinic. This is called an infusion or, more specifically, an immunotherapy infusion. […] In cases of advanced SCLC, the checkpoint inhibitors Tecentriq and Imfinzi can be used along with certain chemotherapy drugs as an initial treatment and they may be continued after chemotherapy as a maintenance treatment. […] For advanced NSCLC patients, Keytruda, Tecentriq or Libtayo can sometimes be paired with chemotherapy as an initial treatment.
  • #68 Patient education: Small cell lung cancer treatment (Beyond the Basics) – UpToDate
    https://www.uptodate.com/contents/small-cell-lung-cancer-treatment-beyond-the-basics/print
    The most commonly used combination of chemotherapy drugs for patients with limited-stage small cell lung cancer is cisplatin plus etoposide. […] An immunotherapy drug, either atezolizumab or durvalumab, is usually added to chemotherapy for people with extensive-stage disease. The addition of immunotherapy to chemotherapy has been shown to prolong duration of treatment response and survival. […] Chemotherapy is of clear benefit in patients with small cell lung cancer, improving both quality of life and duration of survival. […] The goal of treatment for people with limited-stage small cell lung cancer is cure, which is achieved in 30 to 35 percent of patients. […] Extensive-stage small cell lung cancer is not considered to be a curable disease. The goals of therapy are to relieve symptoms, maintain quality of life, and prolong patient survival.
  • #69 Non-Small Cell Lung Cancer (NSCLC) Treatment Protocols: Treatment Recommendations, Early or Localized Disease, Treatment of Locally Advanced Disease, First-Line Therapy, Metastatic (Stage IV) or Recurrent Disease
    https://emedicine.medscape.com/article/2007153-overview
    Patients with advanced or recurrent disease with actionable oncogenes should be considered for treatment with targeted therapy. Patients without an actionable genetic alteration should be treated with chemotherapy alone, chemotherapy with immunotherapy, or immunotherapy alone. […] First-line treatment options for patients who are not candidates for targeted therapy are listed below. Unless otherwise specified, the goal is to treat for four to six cycles. […] Single-agent therapy is a reasonable first-line option in patients with good performance status (ECOG score 2) or in the elderly; the goal is to complete four to six cycles. […] Pembrolizumab is indicated as first-line monotherapy for patients with stage III NSCLC who are not candidates for surgical resection or definitive chemoradiation, or with metastatic NSCLC, and whose tumors express PD-L1 (TPS 1%) with no EGFR or ALK genomic tumor aberrations.
  • #70 Non-small Cell Lung Cancer Treatment by Stage | American Cancer Society
    https://www.cancer.org/cancer/types/lung-cancer/treating-non-small-cell/by-stage.html
    The treatment options for non-small cell lung cancer (NSCLC) are based mainly on the stage (extent) of the cancer, but other factors, such as a persons overall health and lung function, as well as certain traits of the cancer itself, are also important. […] If you smoke: One of the most important things you can do to be ready for treatment is to try to quit. Studies have shown that people who stop smoking after a diagnosis of lung cancer tend to have better outcomes than those who dont. […] Because stage 0 NSCLC is limited to the lining layer of the airways and has not invaded deeper into the lung tissue or other areas, it is usually curable by surgery alone. No chemotherapy or radiation therapy is needed. […] If you have stage I NSCLC, surgery may be the only treatment you need. Surgery will either take out the lobe of the lung that has the tumor (lobectomy) or take out a smaller piece of the lung (sleeve resection, segmentectomy, or wedge resection).
  • #71 Non-Small Cell Lung Cancer Treatment – NCI
    https://www.cancer.gov/types/lung/patient/non-small-cell-lung-treatment-pdq
    Radiation therapy is a cancer treatment that uses high-energy x-rays or other types of radiation to kill cancer cells or keep them from growing. […] Chemotherapy uses drugs to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. […] Targeted therapy uses drugs or other substances to identify and attack specific cancer cells. […] Immunotherapy helps a person’s immune system fight cancer. […] Treatment of occult non-small cell lung cancer depends on the stage of the disease. Occult tumors are often found at an early stage (the tumor is in the lung only) and sometimes can be cured by surgery. […] Treatment of stage 0 may include: surgery (wedge resection or segmental resection), photodynamic therapy, electrocautery, cryosurgery, or laser surgery for tumors in or near the bronchus.
  • #72 Non-Small Cell Lung Cancer Treatment – NCI
    https://www.cancer.gov/types/lung/patient/non-small-cell-lung-treatment-pdq
    Radiation therapy is a cancer treatment that uses high-energy x-rays or other types of radiation to kill cancer cells or keep them from growing. […] Chemotherapy uses drugs to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. […] Targeted therapy uses drugs or other substances to identify and attack specific cancer cells. […] Immunotherapy helps a person’s immune system fight cancer. […] Treatment of occult non-small cell lung cancer depends on the stage of the disease. Occult tumors are often found at an early stage (the tumor is in the lung only) and sometimes can be cured by surgery. […] Treatment of stage 0 may include: surgery (wedge resection or segmental resection), photodynamic therapy, electrocautery, cryosurgery, or laser surgery for tumors in or near the bronchus.
  • #73 Non-Small Cell Lung Cancer Treatment – NCI
    https://www.cancer.gov/types/lung/patient/non-small-cell-lung-treatment-pdq
    Treatment of stage I non-small cell lung cancer and stage IB non-small cell lung cancer may include: surgery (wedge resection, segmental resection, sleeve resection, or lobectomy), surgery followed by targeted therapy, surgery followed by chemotherapy and immunotherapy, external radiation therapy, including stereotactic body radiation therapy for people who cannot have surgery or choose not to have surgery. […] Treatment of stage II non-small cell lung cancer and stage IIB non-small cell lung cancer may include: surgery (wedge resection, segmental resection, sleeve resection, lobectomy, or pneumonectomy), surgery followed by chemotherapy, surgery followed by targeted therapy, surgery followed by chemotherapy and immunotherapy, surgery followed by immunotherapy, surgery followed by radiation therapy, chemotherapy followed by surgery, immunotherapy and chemotherapy followed by surgery, immunotherapy and chemotherapy followed by surgery and more immunotherapy, external radiation therapy for people who cannot have surgery.
  • #74 Non-small Cell Lung Cancer Treatment by Stage | American Cancer Society
    https://www.cancer.org/cancer/types/lung-cancer/treating-non-small-cell/by-stage.html
    The treatment options for non-small cell lung cancer (NSCLC) are based mainly on the stage (extent) of the cancer, but other factors, such as a persons overall health and lung function, as well as certain traits of the cancer itself, are also important. […] If you smoke: One of the most important things you can do to be ready for treatment is to try to quit. Studies have shown that people who stop smoking after a diagnosis of lung cancer tend to have better outcomes than those who dont. […] Because stage 0 NSCLC is limited to the lining layer of the airways and has not invaded deeper into the lung tissue or other areas, it is usually curable by surgery alone. No chemotherapy or radiation therapy is needed. […] If you have stage I NSCLC, surgery may be the only treatment you need. Surgery will either take out the lobe of the lung that has the tumor (lobectomy) or take out a smaller piece of the lung (sleeve resection, segmentectomy, or wedge resection).
  • #75 Non-Small Cell Lung Cancer Treatment – NCI
    https://www.cancer.gov/types/lung/patient/non-small-cell-lung-treatment-pdq
    Treatment of stage I non-small cell lung cancer and stage IB non-small cell lung cancer may include: surgery (wedge resection, segmental resection, sleeve resection, or lobectomy), surgery followed by targeted therapy, surgery followed by chemotherapy and immunotherapy, external radiation therapy, including stereotactic body radiation therapy for people who cannot have surgery or choose not to have surgery. […] Treatment of stage II non-small cell lung cancer and stage IIB non-small cell lung cancer may include: surgery (wedge resection, segmental resection, sleeve resection, lobectomy, or pneumonectomy), surgery followed by chemotherapy, surgery followed by targeted therapy, surgery followed by chemotherapy and immunotherapy, surgery followed by immunotherapy, surgery followed by radiation therapy, chemotherapy followed by surgery, immunotherapy and chemotherapy followed by surgery, immunotherapy and chemotherapy followed by surgery and more immunotherapy, external radiation therapy for people who cannot have surgery.
  • #76 Non-Small Cell Lung Cancer (NSCLC) Treatment & Management: Approach Considerations, Surgical Treatment, Radiation Therapy
    https://emedicine.medscape.com/article/279960-treatment
    Stage IA – Surgery only; no adjuvant chemotherapy […] Stage IB-IIIA – Surgery followed by adjuvant chemotherapy with four cycles of a cisplatin-based regimen and, in cases with an EGFR exon 19 deletion or exon 21 L858R mutation, adjuvant osimertinib […] Stage II-IIIB – If surgically unresectable, chemoradiation plus durvalumab for one year if chemoradiation results in a partial or complete response […] Stage IV – Treat on the basis of histology (squamous or non-squamous) and molecular profile and biomarkers. […] The role of adjuvant radiation therapy after resection of the primary tumor remains controversial. […] Radiation therapy reduces local failures in completely resected (stages II and IIIA) NSCLC but has not been shown to improve overall survival rates. […] A single phase III study using small fractions, with 3D treatment planning, showed a 5-year survival benefit in the radiation treatment arm.
  • #77 Non-Small Cell Lung Cancer Treatment – NCI
    https://www.cancer.gov/types/lung/patient/non-small-cell-lung-treatment-pdq
    Treatment of stage IIIA non-small cell lung cancer that can be removed with surgery may include: chemotherapy followed by surgery, chemotherapy and radiation therapy followed by surgery, immunotherapy and chemotherapy followed by surgery, immunotherapy and chemotherapy followed by surgery and more immunotherapy, surgery followed by chemotherapy, surgery followed by targeted therapy, surgery followed by chemotherapy and immunotherapy, surgery followed by immunotherapy, surgery followed by chemotherapy and radiation therapy, surgery followed by radiation therapy. […] Treatment of newly stage IV, relapsed, and recurrent non-small cell lung cancer may include: one or more chemotherapy drugs with or without targeted therapy, combination chemotherapy followed by more chemotherapy as maintenance therapy to help keep cancer from progressing, targeted therapy, one or more immunotherapy drugs. […] Treatment of progressive stage IV, relapsed, and recurrent non-small cell lung cancer may include: chemotherapy, targeted therapy with or without chemotherapy, immunotherapy.
  • #78 Non-Small Cell Lung Cancer (NSCLC) Treatment & Management: Approach Considerations, Surgical Treatment, Radiation Therapy
    https://emedicine.medscape.com/article/279960-treatment
    The current standard of care in the management of good-risk (ie, Karnofsky performance score of 70-100, minimal weight loss) patients with locally advanced unresectable (stage IIIA) NSCLC is combined-modality therapy consisting of platinum-based chemotherapy in conjunction with radiation therapy. […] This combination results in statistically significant improvement in both disease-free and overall survival rates compared with either modality used alone. […] Randomized studies show longer survival in patients with unresectable stage III disease when treated with concurrent (rather than sequential) platinum-based chemotherapy and radiation therapy. […] Consolidation chemotherapy after chemoradiation had initially been shown to be beneficial in phase 2 studies, with docetaxel after chemoradiation with cisplatin/etoposide showing a median survival of 26 months and a 5-year survival of 29%.
  • #79 Non-small Cell Lung Cancer Treatment by Stage | American Cancer Society
    https://www.cancer.org/cancer/types/lung-cancer/treating-non-small-cell/by-stage.html
    For people with stage I NSCLC that has a higher risk of coming back (based on size, location, or other factors), chemotherapy, immunotherapy, and possibly targeted therapy (ie. alectinib, osimertinib) after surgery may lower the risk that cancer will return. This is called adjuvant treatment. […] Neoadjuvant (pre-operative) chemotherapy with or without immunotherapy is usually offered to patients with stage II NSCLC. […] The initial treatment for stage IIIA NSCLC may include some combination of radiation therapy, chemotherapy (chemo), immunotherapy, and/or surgery. […] Stage IIIB NSCLC has spread to lymph nodes that are near the other lung or in the neck, and may also have grown into important structures in the chest. These cancers cant be removed completely by surgery. […] Stage IVA or IVB NSCLC has already spread when it is diagnosed. These cancers can be very hard to cure. Treatment options depend on where and how far the cancer has spread, whether the cancer cells have certain gene or protein changes, and your overall health. […] If cancer continues to grow during treatment (progresses) or comes back (recurs), further treatment will depend on the location and extent of the cancer, what treatments have been used, and on the persons health and desire for more treatment.
  • #80 Non-Small Cell Lung Cancer (NSCLC) Treatment & Management: Approach Considerations, Surgical Treatment, Radiation Therapy
    https://emedicine.medscape.com/article/279960-treatment
    Stage IA – Surgery only; no adjuvant chemotherapy […] Stage IB-IIIA – Surgery followed by adjuvant chemotherapy with four cycles of a cisplatin-based regimen and, in cases with an EGFR exon 19 deletion or exon 21 L858R mutation, adjuvant osimertinib […] Stage II-IIIB – If surgically unresectable, chemoradiation plus durvalumab for one year if chemoradiation results in a partial or complete response […] Stage IV – Treat on the basis of histology (squamous or non-squamous) and molecular profile and biomarkers. […] The role of adjuvant radiation therapy after resection of the primary tumor remains controversial. […] Radiation therapy reduces local failures in completely resected (stages II and IIIA) NSCLC but has not been shown to improve overall survival rates. […] A single phase III study using small fractions, with 3D treatment planning, showed a 5-year survival benefit in the radiation treatment arm.
  • #81 Non-Small Cell Lung Cancer Treatment – NCI
    https://www.cancer.gov/types/lung/patient/non-small-cell-lung-treatment-pdq
    Treatment of stage IIIA non-small cell lung cancer that can be removed with surgery may include: chemotherapy followed by surgery, chemotherapy and radiation therapy followed by surgery, immunotherapy and chemotherapy followed by surgery, immunotherapy and chemotherapy followed by surgery and more immunotherapy, surgery followed by chemotherapy, surgery followed by targeted therapy, surgery followed by chemotherapy and immunotherapy, surgery followed by immunotherapy, surgery followed by chemotherapy and radiation therapy, surgery followed by radiation therapy. […] Treatment of newly stage IV, relapsed, and recurrent non-small cell lung cancer may include: one or more chemotherapy drugs with or without targeted therapy, combination chemotherapy followed by more chemotherapy as maintenance therapy to help keep cancer from progressing, targeted therapy, one or more immunotherapy drugs. […] Treatment of progressive stage IV, relapsed, and recurrent non-small cell lung cancer may include: chemotherapy, targeted therapy with or without chemotherapy, immunotherapy.
  • #82 Non-Small Cell Lung Cancer (NSCLC) Treatment Protocols: Treatment Recommendations, Early or Localized Disease, Treatment of Locally Advanced Disease, First-Line Therapy, Metastatic (Stage IV) or Recurrent Disease
    https://emedicine.medscape.com/article/2007153-overview
    Patients with advanced or recurrent disease with actionable oncogenes should be considered for treatment with targeted therapy. Patients without an actionable genetic alteration should be treated with chemotherapy alone, chemotherapy with immunotherapy, or immunotherapy alone. […] First-line treatment options for patients who are not candidates for targeted therapy are listed below. Unless otherwise specified, the goal is to treat for four to six cycles. […] Single-agent therapy is a reasonable first-line option in patients with good performance status (ECOG score 2) or in the elderly; the goal is to complete four to six cycles. […] Pembrolizumab is indicated as first-line monotherapy for patients with stage III NSCLC who are not candidates for surgical resection or definitive chemoradiation, or with metastatic NSCLC, and whose tumors express PD-L1 (TPS 1%) with no EGFR or ALK genomic tumor aberrations.
  • #83 Non-Small Cell Lung Cancer (NSCLC) Treatment & Management: Approach Considerations, Surgical Treatment, Radiation Therapy
    https://emedicine.medscape.com/article/279960-treatment
    Stage IA – Surgery only; no adjuvant chemotherapy […] Stage IB-IIIA – Surgery followed by adjuvant chemotherapy with four cycles of a cisplatin-based regimen and, in cases with an EGFR exon 19 deletion or exon 21 L858R mutation, adjuvant osimertinib […] Stage II-IIIB – If surgically unresectable, chemoradiation plus durvalumab for one year if chemoradiation results in a partial or complete response […] Stage IV – Treat on the basis of histology (squamous or non-squamous) and molecular profile and biomarkers. […] The role of adjuvant radiation therapy after resection of the primary tumor remains controversial. […] Radiation therapy reduces local failures in completely resected (stages II and IIIA) NSCLC but has not been shown to improve overall survival rates. […] A single phase III study using small fractions, with 3D treatment planning, showed a 5-year survival benefit in the radiation treatment arm.
  • #84 Small Cell Lung Cancer Treatment (PDQ®) – PDQ Cancer Information Summaries – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/books/NBK65909/
    This PDQ cancer information summary for health professionals provides comprehensive, peer-reviewed, evidence-based information about the treatment of small cell lung cancer. It is intended as a resource to inform and assist clinicians in the care of their patients. It does not provide formal guidelines or recommendations for making health care decisions. […] SCLC is more responsive to chemotherapy and radiation therapy than other cell types of lung cancer. However, a cure is difficult to achieve because SCLC has a greater tendency to be widely disseminated by the time of diagnosis. […] Treatment options for patients are determined by histology, stage, and general health and comorbidities of the patient. […] Chemotherapy improves the survival of patients with limited-stage disease (LD) or extensive-stage disease (ED), but it is curative in only a few patients.
  • #85 Patient education: Small cell lung cancer treatment (Beyond the Basics) – UpToDate
    https://www.uptodate.com/contents/small-cell-lung-cancer-treatment-beyond-the-basics/print
    Lung cancer is categorized into two basic disease types: small cell lung cancer and non-small cell lung cancer based on the appearance of the cancer cells under the microscope and the behavior of the disease. Small cell lung cancer makes up about 15 percent of all lung cancers, with the remainder being non-small cell lung cancer. […] Small cell lung cancer occurs almost exclusively in smokers, particularly heavy smokers, and former smokers. It is usually an aggressive cancer that tends to grow and spread quickly. Because of this, surgery is useful for very few patients with small cell lung cancer. […] Most people with limited-stage small cell lung cancer are treated with chemotherapy in combination with radiation therapy directed at the disease in the chest. After this initial treatment, patients are frequently treated with radiation therapy to the brain in order to prevent the development of brain metastases and to improve survival. The addition of immunotherapy after the completion of chemotherapy and radiation therapy has also been shown to improve survival in some patients. The goal of treatment for limited-stage disease is to cure the patient of the cancer.
  • #86 Small Cell Lung Cancer Treatment (PDQ®) – PDQ Cancer Information Summaries – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/books/NBK65909/
    The combination of platinum and etoposide is the most widely used standard chemotherapeutic regimen. […] SCLC is highly radiosensitive and thoracic radiation therapy improves survival of patients with LD and ED tumors. […] Prophylactic cranial irradiation prevents central nervous system recurrence and may improve the long-term survival of patients with good performance status who have responded to chemoradiation therapy. […] Combined-modality treatment with etoposide and cisplatin with thoracic radiation therapy (TRT) is the most widely used treatment for patients with limited-stage disease (LD) SCLC. […] Patients with LD have improved long-term survival with combined-modality therapy. […] Patients diagnosed with LD who smoke should be encouraged to stop smoking before undergoing combined-modality therapy because continued smoking may compromise survival.
  • #87 Patient education: Small cell lung cancer treatment (Beyond the Basics) – UpToDate
    https://www.uptodate.com/contents/small-cell-lung-cancer-treatment-beyond-the-basics/print
    Lung cancer is categorized into two basic disease types: small cell lung cancer and non-small cell lung cancer based on the appearance of the cancer cells under the microscope and the behavior of the disease. Small cell lung cancer makes up about 15 percent of all lung cancers, with the remainder being non-small cell lung cancer. […] Small cell lung cancer occurs almost exclusively in smokers, particularly heavy smokers, and former smokers. It is usually an aggressive cancer that tends to grow and spread quickly. Because of this, surgery is useful for very few patients with small cell lung cancer. […] Most people with limited-stage small cell lung cancer are treated with chemotherapy in combination with radiation therapy directed at the disease in the chest. After this initial treatment, patients are frequently treated with radiation therapy to the brain in order to prevent the development of brain metastases and to improve survival. The addition of immunotherapy after the completion of chemotherapy and radiation therapy has also been shown to improve survival in some patients. The goal of treatment for limited-stage disease is to cure the patient of the cancer.
  • #88 Lung Cancer Chemotherapy
    https://www.froedtert.com/lung-cancer/treatment/chemotherapy
    Chemotherapy is the treatment backbone for a significant number of lung cancer patients. […] The standard treatment approach for small cell lung cancer that has not spread is chemotherapy and radiation given at the same time. […] More advanced stages are generally treated with chemotherapy first and may be followed by radiation therapy to the chest, the brain, and other sites of disease depending on the response to chemotherapy and symptoms. […] Currently, 10 – 12 chemotherapy drugs are recommended for treating non-small cell lung cancer. […] The best chance for a cure for thoracic mesothelioma is through a combination of surgery, chemotherapy and radiation therapy. […] If lung cancer is confined to the lung (Stage I) and surgically removed, chemotherapy is sometimes given to prevent recurrence. This is considered curative chemotherapy.
  • #89 Patient education: Small cell lung cancer treatment (Beyond the Basics) – UpToDate
    https://www.uptodate.com/contents/small-cell-lung-cancer-treatment-beyond-the-basics/print
    Patients with extensive-stage small cell lung cancer are generally treated with chemotherapy and immunotherapy; surgery is not an option. Extensive-stage disease is not considered to be curable, and the goals of treatment are to relieve symptoms caused by the cancer and to prolong life. […] Systemic therapy refers to medicines that go throughout the body to kill cancer cells wherever they might be. For small cell lung cancer, systemic therapy generally consists of chemotherapy with or without immunotherapy. Chemotherapy refers to the use of medicines to either kill cancer cells or stop their growth. It is the mainstay of treatment for small cell lung cancer. […] The optimal duration of initial chemotherapy or chemotherapy plus immunotherapy for people with small cell lung cancer is determined by how the cancer is responding to treatment, and how the patient’s body tolerates the treatment. Typically, four to six cycles of initial chemotherapy with or without immunotherapy are recommended.
  • #90 Treatment for lung cancer | NICE
    https://www.nice.org.uk/about/what-we-do/into-practice/measuring-the-use-of-nice-guidance/impact-of-our-guidance/niceimpact-lung-cancer/ch4-treatment-for-lung-cancer
    NICE recommends that twice-daily radiotherapy with concurrent chemotherapy should be offered to people with limited-stage disease SCLC. […] NICE also says that surgery should be considered in people with early-stage SCLC. […] NICE recommends that people with limited-stage SCLC should be offered 4 to 6 cycles of cisplatin-based combination chemotherapy and that people with extensive-stage SCLC should be offered a platinum-based combination chemotherapy.
  • #91 Treatments for Small Cell Lung Cancer: What’s new | LCFA
    https://lcfamerica.org/treatment/small-cell-lung-cancer-sclc/
    Your healthcare team will also discuss your treatment options with you. For small cell lung cancer, the treatments aim to control the cancer, help ease symptoms, and improve your quality of life. Chemotherapy is a common treatment for SCLC because this type of cancer tends to respond well to these drugs. […] Sometimes, doctors may also recommend radiation therapy, especially if the cancer is in the limited stage. They might even combine radiation with chemotherapy for a stronger attack on the cancer cells. And, as discussed above, sometimes chemotherapy is combined with immunotherapy for extensive stage SCLC patients.
  • #92 Small Cell Lung Cancer Treatment (PDQ®) – PDQ Cancer Information Summaries – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/books/NBK65909/
    Patients with extensive-stage disease (ED) SCLC have a median survival of 6 to 12 months with currently available therapy, but long-term disease-free survival is rare. […] Despite treatment advances, most patients with SCLC die of their tumor even with the best available therapy. […] Patients with recurrent SCLC may receive chemotherapy, immunotherapy, immune checkpoint modulation, palliative therapy, and participate in phase I and II clinical trials evaluating new drugs. […] At the time of recurrence, many patients with SCLC are potential candidates for further therapy. […] For patients with recurrent SCLC, immune checkpoint modulation with antiprogrammed death-ligand 1 (anti-PD-L1) antibodies may lead to durable responses either as single agents or in combination with cytotoxic T lymphocyte antigen-4 (anti-CTLA-4).
  • #93 Treatments for Small Cell Lung Cancer: What’s new | LCFA
    https://lcfamerica.org/treatment/small-cell-lung-cancer-sclc/
    The immunotherapy drugs atezolizumab and durvalumab block the protein PD-L1 and boost the bodys immune response to cancer cells. When used in combination with chemotherapy, these drugs increased overall survival (OS) and progression-free survival (PFS) from chemotherapy alone. […] In February of 2021, the FDA approved the drug trilaciclib (Coasela) for patients with extensive-stage SCLC undergoing chemotherapy. Trilaciclib limits the damage chemotherapy causes to bone marrow, called myelosuppression. This treatment makes patients less susceptible to fatigue and infection and less likely to need rescue interventions during treatment. They are more likely to finish their treatment on schedule. […] In 2020, the FDA approved the new chemotherapy drug lurbinectedin (Zepzelca) to treat metastatic SCLC that has progressed on or after platinum-based chemotherapy. Lubinectedin works by selectively blocking oncogenic transcription, or the process by which tumor cells reproduce. It interferes with the tumor cells reproduction cycle and causes cell death.
  • #94 Small Cell Lung Cancer Treatment (PDQ®) – PDQ Cancer Information Summaries – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/books/NBK65909/
    Topotecan is a standard chemotherapy for recurrent SCLC. […] Lurbinectedin, a selective inhibitor of oncogenic transcription, is another option. […] Patients with sensitive disease may achieve response to a number of agents including topotecan, irinotecan, taxanes, vinorelbine, paclitaxel, or gemcitabine. […] Patients with central nervous system (CNS) recurrences can often obtain palliation of symptoms with additional chemotherapy and/or radiation therapy. […] Patients with progressive intrathoracic tumor after failing initial chemotherapy can achieve significant tumor responses, palliation of symptoms, and short-term local control with external-beam radiation therapy. […] Combination chemotherapy plus chest radiation therapy does not appear to improve survival compared with chemotherapy alone in patients with ED SCLC.
  • #95 Lung cancer – Diagnosis and treatment – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/lung-cancer/diagnosis-treatment/drc-20374627
    Immunotherapy for cancer is a treatment with medicine that helps the body’s immune system to kill cancer cells. The immune system fights off diseases by attacking germs and other cells that shouldn’t be in the body. Cancer cells survive by hiding from the immune system. Immunotherapy helps the immune system cells find and kill the cancer cells. […] Palliative care is a special type of healthcare that helps you feel better when you have a serious illness. If you have cancer, palliative care can help relieve pain and other symptoms. A healthcare team that may include doctors, nurses and other specially trained health professionals provides palliative care. The care team’s goal is to improve quality of life for you and your family. […] The use of palliative care with other proper treatments can help people with cancer feel better and live longer.
  • #96 Lung Cancer Treatment
    https://www.radiologyinfo.org/en/info/lung-cancer-therapy
    Besides attacking the tumor, radiotherapy can help relieve symptoms such as bleeding, cough, and pain. […] Patients who have a small, localized lung cancer, but are not candidates for surgery, may receive stereotactic body radiation therapy (SBRT). […] Most often, radiation therapy uses the external beam technique, which aims a beam of x-rays or protons directly at the tumor. […] Doctors use systemic therapies to treat cancer that has already or is likely to spread throughout the body. […] Chemotherapy uses drugs that kill cancer cells. […] Targeted therapy uses man-made molecules called monoclonal antibodies. […] Immunotherapy uses the body’s immune system to fight cancer. […] Treatment effectiveness depends on the stage of disease. In early stage inoperable disease that is treated with radiotherapy alone, control of the local disease is typical.
  • #97 Treatment for lung cancer | Cancer Research UK
    https://www.cancerresearchuk.org/about-cancer/lung-cancer/treatment
    Doctors can use heat to destroy tumours that started in the lung. […] Diathermy treatment uses an electrical current to heat and destroy cancer cells. […] Some treatments can help you breathe more easily. […] Cryotherapy is a treatment for metastatic lung cancer that freezes cancer cells. It can shrink a tumour that is blocking an airway. […] A stent is a hollow tube that may be placed in your airway. It opens the narrowed area and helps you breathe. […] After treatment for lung cancer, you have regular check ups at the hospital. You also have tests including blood tests, x-rays and scans.
  • #98 Non-Small Cell Lung Cancer (NSCLC) Treatment & Management: Approach Considerations, Surgical Treatment, Radiation Therapy
    https://emedicine.medscape.com/article/279960-treatment
    Surgery is the treatment of choice for patients with nonsmall cell lung cancer (NSCLC) stages I through IIIA. […] In addition, patients with resected lung cancer have a high risk of relapse and so are treated with adjuvant chemotherapy. […] Patients with stage IIIB and IV NSCLC are usually offered chemotherapy with the option of surgery. Molecular-targeted therapy plays an increasingly important role in the treatment of advanced NSCLC. […] The success of molecular-targeted therapy in advanced NSCLC has raised interest in preoperative therapy of resectable early-stage NSCLC. […] In 2022, the US Food and Drug Administration (FDA) approved the neoadjuvant use of the immune checkpoint inhibitor nivolumab, in combination with platinum-doublet chemotherapy, for patients with resectable NSCLC (tumors 4 cm or node positive).
  • #99 Lung Cancer Treatment
    https://www.radiologyinfo.org/en/info/lung-cancer-therapy
    Besides attacking the tumor, radiotherapy can help relieve symptoms such as bleeding, cough, and pain. […] Patients who have a small, localized lung cancer, but are not candidates for surgery, may receive stereotactic body radiation therapy (SBRT). […] Most often, radiation therapy uses the external beam technique, which aims a beam of x-rays or protons directly at the tumor. […] Doctors use systemic therapies to treat cancer that has already or is likely to spread throughout the body. […] Chemotherapy uses drugs that kill cancer cells. […] Targeted therapy uses man-made molecules called monoclonal antibodies. […] Immunotherapy uses the body’s immune system to fight cancer. […] Treatment effectiveness depends on the stage of disease. In early stage inoperable disease that is treated with radiotherapy alone, control of the local disease is typical.
  • #100 Treatment for lung cancer | Cancer Research UK
    https://www.cancerresearchuk.org/about-cancer/lung-cancer/treatment
    Chemotherapy uses anti cancer (cytotoxic) drugs to destroy cancer cells. You might have chemotherapy for small cell lung cancer and non small cell lung cancer. […] Chemoradiotherapy means having chemotherapy and radiotherapy treatment together. You might have this as part of your treatment for small cell and non small cell lung cancer. […] Targeted cancer drugs work by targeting the differences in cancer cells that help them to grow and survive. Other drugs help the immune system to attack cancer. They are called immunotherapies. […] There are treatments available that can try to make you feel more comfortable. […] Photodynamic therapy kills cancer cells by using a combination of a light sensitising drug and a very bright light. […] A laser is a very thin, focused beam of light that heats and destroys tissue.
  • #101 Treatment for lung cancer | Cancer Research UK
    https://www.cancerresearchuk.org/about-cancer/lung-cancer/treatment
    Doctors can use heat to destroy tumours that started in the lung. […] Diathermy treatment uses an electrical current to heat and destroy cancer cells. […] Some treatments can help you breathe more easily. […] Cryotherapy is a treatment for metastatic lung cancer that freezes cancer cells. It can shrink a tumour that is blocking an airway. […] A stent is a hollow tube that may be placed in your airway. It opens the narrowed area and helps you breathe. […] After treatment for lung cancer, you have regular check ups at the hospital. You also have tests including blood tests, x-rays and scans.
  • #102 Treatment for lung cancer | Cancer Research UK
    https://www.cancerresearchuk.org/about-cancer/lung-cancer/treatment
    Doctors can use heat to destroy tumours that started in the lung. […] Diathermy treatment uses an electrical current to heat and destroy cancer cells. […] Some treatments can help you breathe more easily. […] Cryotherapy is a treatment for metastatic lung cancer that freezes cancer cells. It can shrink a tumour that is blocking an airway. […] A stent is a hollow tube that may be placed in your airway. It opens the narrowed area and helps you breathe. […] After treatment for lung cancer, you have regular check ups at the hospital. You also have tests including blood tests, x-rays and scans.
  • #103 Lung cancer – Symptoms and causes – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/lung-cancer/symptoms-causes/syc-20374620
    Lung cancer is the leading cause of cancer deaths worldwide. […] Lung cancer is divided into two major types based on the appearance of the cells under a microscope. Your healthcare professional makes treatment decisions based on which major type of lung cancer you have. […] The two general types of lung cancer include: Small cell lung cancer usually only happens in people who have smoked heavily for years. Small cell lung cancer is less common than non-small cell lung cancer. Non-small cell lung cancer is a category that includes several types of lung cancers. Non-small cell lung cancers include squamous cell carcinoma, adenocarcinoma and large cell carcinoma. […] Treatments are available to control bleeding. […] Many treatments are available to control pain. […] Treatments are available to drain the fluid from your chest. Treatments can reduce the risk that pleural effusion will happen again.
  • #104 Lung Cancer Treatment
    https://www.radiologyinfo.org/en/info/lung-cancer-therapy
    When cure is not a possibility, doctors recommend palliative treatment. […] Pain relief is a very important part of treating lung cancer. […] Radiation therapy delivers focused high-energy x-rays (photons), gamma rays, or atomic particles. […] Overall, radiotherapy is a local treatment. […] Most patients tire easily during their course of radiation treatment. […] Skin irritation is common after a few weeks of radiation therapy. […] An inflammation of the lungs called radiation pneumonitis may develop three to six months after radiotherapy is over. […] Once radiotherapy ends, your doctor will want to see you after four to six weeks and then every three to six months for the first two years. […] Any lung cancer patient should consider taking part in a clinical trial to help find more effective treatments for lung cancer. […] Less invasive surgical methods are under study. […] Angiogenesis inhibitors are agents that prevent new blood vessels from forming in growing cancers and may shut off the tumor’s blood supply.
  • #105 Symptoms And Side Effects Of Lung Cancer Treatment | LCRF
    https://www.lungcancerresearchfoundation.org/for-patients/living-with-lung-cancer/symptoms-and-side-effects/
    How can I manage my lung cancer symptoms and side effects from treatment? You may experience symptoms from your cancer or side effects from your cancer treatments. Be sure to tell your cancer treatment team about any symptoms you are experiencing so they can determine if supportive or palliative care is appropriate. In most cases, these symptoms can be controlled with medications, exercises, or other therapies to help you feel better and continue with your daily life. […] Side effects of treatment will vary. Immunotherapy side effects are treated differently than those of chemotherapy. Depending on the side effects, your dose of immunotherapy could be changed, treatment could be stopped, or corticosteroid therapy might be used. Be sure to talk to your doctor about any concerns or side effects you experience. […] Possible side effects by treatment type […] Chemotherapy […] Immunotherapy […] If you are on an immunotherapy, your side effects may be treated differently than those of chemotherapy or targeted therapy.
  • #106 Lung cancer – Diagnosis and treatment – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/lung-cancer/diagnosis-treatment/drc-20374627
    Immunotherapy for cancer is a treatment with medicine that helps the body’s immune system to kill cancer cells. The immune system fights off diseases by attacking germs and other cells that shouldn’t be in the body. Cancer cells survive by hiding from the immune system. Immunotherapy helps the immune system cells find and kill the cancer cells. […] Palliative care is a special type of healthcare that helps you feel better when you have a serious illness. If you have cancer, palliative care can help relieve pain and other symptoms. A healthcare team that may include doctors, nurses and other specially trained health professionals provides palliative care. The care team’s goal is to improve quality of life for you and your family. […] The use of palliative care with other proper treatments can help people with cancer feel better and live longer.
  • #107 Non-Small Cell Lung Cancer (NSCLC) Treatment & Management: Approach Considerations, Surgical Treatment, Radiation Therapy
    https://emedicine.medscape.com/article/279960-treatment
    Radiation is a reasonable option for treatment in patients who are not candidates for surgery. The role of adjuvant radiation therapy after resection of the primary tumor remains controversial. […] Because most NSCLC cannot be cured with currently available therapeutic modalities, the appropriate application of skilled palliative care is an important part of treatment. […] Increasing evidence supports offering palliative care concurrently with standard oncologic care at the initial diagnosis of advanced NSCLC. […] For example, a clinical trial found that patients with metastatic NSCLC randomized to early palliative care had a better quality of life and, surprisingly, longer median survival than those randomized to standard oncologic care alone. […] Treatment of NSCLC by stage is as follows:
  • #108 Treatment Options for Lung Cancer | LUNGevity Foundation
    https://www.lungevity.org/for-patients-caregivers/navigating-your-diagnosis/treatment-options-for-lung-cancer
    Tumor treating fields are electrical fields that disrupt the division of cancer cells and are delivered by a noninvasive wearable device. […] Angiogenesis inhibitor drugs focus on stopping the formation of blood vessels that help cancerous tumors grow. […] Clinical trials give access to a wide range of new treatments that are not yet available, with the added benefit of being under close medical supervision. […] Palliative care, sometimes called supportive care, is given in addition to standard treatment. The goal is to improve quality of life by focusing on managing symptoms of the disease and side effects of treatment. […] Hospice care is an end-of-life form of palliative care focused on comfort and quality of life. Hospice care is intended for people who choose not to have curative treatment or for whom other treatment options have been unsuccessful.
  • #109 Lung Cancer Treatment
    https://www.radiologyinfo.org/en/info/lung-cancer-therapy
    When cure is not a possibility, doctors recommend palliative treatment. […] Pain relief is a very important part of treating lung cancer. […] Radiation therapy delivers focused high-energy x-rays (photons), gamma rays, or atomic particles. […] Overall, radiotherapy is a local treatment. […] Most patients tire easily during their course of radiation treatment. […] Skin irritation is common after a few weeks of radiation therapy. […] An inflammation of the lungs called radiation pneumonitis may develop three to six months after radiotherapy is over. […] Once radiotherapy ends, your doctor will want to see you after four to six weeks and then every three to six months for the first two years. […] Any lung cancer patient should consider taking part in a clinical trial to help find more effective treatments for lung cancer. […] Less invasive surgical methods are under study. […] Angiogenesis inhibitors are agents that prevent new blood vessels from forming in growing cancers and may shut off the tumor’s blood supply.
  • #110 New Lung Cancer Treatments Aim to Reduce Deaths in 2025 and Beyond | Memorial Sloan Kettering Cancer Center
    https://www.mskcc.org/news/new-lung-cancer-treatments-aim-to-reduce-deaths-in-2025-and-beyond
    Thoracic medical oncologist Dr. Mark Awad says new treatments for lung cancer include a growing number of targeted therapies and new forms of immunotherapy. […] Exciting new treatments have emerged in recent years both for early-stage tumors (stage 1, 2, or 3) that can be surgically removed, and for more advanced stage 4 lung cancers that have spread (metastasized). […] At MSK, more than 90% of lung cancer surgeries for early-stage disease (stage 1) now use minimally invasive approaches such as video-assisted thoracic surgery (VATS) and robotic-assisted surgery. This usually results in less pain and fewer complications. It also enables patients who may need chemotherapy or radiation therapy to start treatment sooner. […] For people with later-stage cancers, many new treatment options have been developed. These include new chemotherapy treatments, new targeted therapies that are matched to specific genetic mutations found within the lung cancer tumor, new immunotherapies, and novel cellular treatments.
  • #111 Small Cell Lung Cancer Treatment (PDQ®) – PDQ Cancer Information Summaries – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/books/NBK65909/
    Patients with recurrent SCLC may receive chemotherapy, immunotherapy, immune checkpoint modulation, palliative therapy, and participate in phase I and II clinical trials evaluating new drugs. […] Patients with recurrent SCLC may receive chemotherapy, immunotherapy, immune checkpoint modulation, palliative therapy, and participate in phase I and II clinical trials evaluating new drugs. […] Patients with recurrent SCLC may receive chemotherapy, immunotherapy, immune checkpoint modulation, palliative therapy, and participate in phase I and II clinical trials evaluating new drugs. […] Patients with recurrent SCLC may receive chemotherapy, immunotherapy, immune checkpoint modulation, palliative therapy, and participate in phase I and II clinical trials evaluating new drugs. […] Patients with recurrent SCLC may receive chemotherapy, immunotherapy, immune checkpoint modulation, palliative therapy, and participate in phase I and II clinical trials evaluating new drugs.
  • #112 Lung Cancer | AstraZeneca
    https://www.astrazeneca.com/our-therapy-areas/oncology/at-the-forefront-of-lung-cancer-treatment.html
    Lung cancer is the leading cause of cancer death worldwide, accounting for about 2.4 million patients diagnosed and 1.8 million deaths each year. The two main types of lung cancer are non-small cell lung cancer (NSCLC), which represents 80-85% of patients, and small cell lung cancer (SCLC), the more aggressive and fast-growing cancer type, representing about 15% of patients. The earlier we can detect and treat lung cancer, the closer we are to cure. Unfortunately, early diagnosis is not always a reality. In many cases, lung cancer goes undetected until it is in advanced stages, or the cancer comes back after initial treatment. For these patients who experience recurrence, outcomes are especially poor. To meaningfully improve outcomes, we are prioritising lung cancer research to increase early screening and diagnosis and address the significant unmet need for treatments at every stage of the disease continuum. Our portfolio of approved and potential new medicines in late-stage development spans different histologies, several stages of disease, lines of therapy and modes of action. Our approach is driven by precision medicine, using groundbreaking science to further our understanding of lung cancer and deliver medicines matched to the patients who can best benefit from them. This includes thinking differently about the underlying biology of lung cancer, from early stages where we aim to help patients live longer and cancer-free to late stages, where we look to meaningfully extend survival. We are defining new biomarkers and therapeutic targets to transform the way lung cancer is diagnosed and treated. Our research has led us to address the unmet needs of patients with mutations in the epidermal growth factor receptor (EGFR). We are also investigating resistance mechanisms and emerging biomarkers, such as alterations in the MET gene, to help answer what comes next for patients whose cancer progresses despite treatment with today’s standard-of-care therapies. We are investigating antibody drug conjugates (ADCs) to target actionable biomarkers such as human epidermal growth factor 2 (HER2). Unlike conventional chemotherapy treatments which can damage healthy cells, ADCs can deliver a cancer drug directly into cancer cells to reduce damage caused to healthy cells. Immunotherapies are designed to target immune checkpoints that are exploited by cancer to avoid or suppress the immune system’s ability to recognise and destroy cancer cells. While many new treatments have focused on advancing care for metastatic patients with a high unmet medical need, we prioritised pushing treatment into earlier lung cancer settings. To really cure cancer, we need to treat earlier to maximise the potential for long-term disease remission and the possibility of cure. In pursuit of this goal, we have launched more than a dozen Phase II and III clinical trials evaluating our Immuno-Oncology and gene-targeted therapies in earlier stages of disease. As a founding member of the Lung Ambition Alliance, a partnership of organisations driving forward meaningful improvements for people with lung cancer, we have the ambitious goal to eliminate lung cancer as a cause of death. To meet this goal, the Alliance advocates for improved approaches in three key areas: Increasing screening rates and diagnostic testing, Accelerating the delivery of innovative medicine, Improving quality of care. Recent and ongoing initiatives include policy reports, like Lung Cancer Screening: The Cost of Inaction which outlines the opportunity presented by lung cancer screening to reduce costs while saving lives; strategic global, regional and local collaborations, like one with Aidence using artificial intelligence to improve early lung cancer diagnoses; the ILC2 grant program which funds non-profit initiatives with transformative potential for patient care; and efforts to study oncology endpoints to accelerate drug approvals in earlier settings of lung cancer.
  • #113 Patient education: Small cell lung cancer treatment (Beyond the Basics) – UpToDate
    https://www.uptodate.com/contents/small-cell-lung-cancer-treatment-beyond-the-basics/print
    The importance of quitting smoking cannot be overemphasized, particularly for patients with limited-stage disease. Patients who continue to smoke do not do as well as those who quit. […] Progress in treating lung cancer requires that better treatments be identified through clinical trials, which are conducted all over the world.
  • #114 Lung Cancer Treatment
    https://www.radiologyinfo.org/en/info/lung-cancer-therapy
    When cure is not a possibility, doctors recommend palliative treatment. […] Pain relief is a very important part of treating lung cancer. […] Radiation therapy delivers focused high-energy x-rays (photons), gamma rays, or atomic particles. […] Overall, radiotherapy is a local treatment. […] Most patients tire easily during their course of radiation treatment. […] Skin irritation is common after a few weeks of radiation therapy. […] An inflammation of the lungs called radiation pneumonitis may develop three to six months after radiotherapy is over. […] Once radiotherapy ends, your doctor will want to see you after four to six weeks and then every three to six months for the first two years. […] Any lung cancer patient should consider taking part in a clinical trial to help find more effective treatments for lung cancer. […] Less invasive surgical methods are under study. […] Angiogenesis inhibitors are agents that prevent new blood vessels from forming in growing cancers and may shut off the tumor’s blood supply.
  • #115 Non-small Cell Lung Cancer Treatment by Stage | American Cancer Society
    https://www.cancer.org/cancer/types/lung-cancer/treating-non-small-cell/by-stage.html
    The treatment options for non-small cell lung cancer (NSCLC) are based mainly on the stage (extent) of the cancer, but other factors, such as a persons overall health and lung function, as well as certain traits of the cancer itself, are also important. […] If you smoke: One of the most important things you can do to be ready for treatment is to try to quit. Studies have shown that people who stop smoking after a diagnosis of lung cancer tend to have better outcomes than those who dont. […] Because stage 0 NSCLC is limited to the lining layer of the airways and has not invaded deeper into the lung tissue or other areas, it is usually curable by surgery alone. No chemotherapy or radiation therapy is needed. […] If you have stage I NSCLC, surgery may be the only treatment you need. Surgery will either take out the lobe of the lung that has the tumor (lobectomy) or take out a smaller piece of the lung (sleeve resection, segmentectomy, or wedge resection).
  • #116 Patient education: Small cell lung cancer treatment (Beyond the Basics) – UpToDate
    https://www.uptodate.com/contents/small-cell-lung-cancer-treatment-beyond-the-basics/print
    The importance of quitting smoking cannot be overemphasized, particularly for patients with limited-stage disease. Patients who continue to smoke do not do as well as those who quit. […] Progress in treating lung cancer requires that better treatments be identified through clinical trials, which are conducted all over the world.
  • #117 Lung cancer
    https://www.cancervic.org.au/cancer-information/types-of-cancer/lung_cancer/treatment-for-early-lung-cancer.html
    Locally advanced (stage 3) can be treated with surgery and chemotherapy, or with radiation therapy and chemotherapy (without surgery). Immunotherapy may also be used. […] Advanced (stage 4) depending on the symptoms, palliative drug treatment (targeted therapy, chemotherapy or immunotherapy), palliative radiation therapy, SBRT, or a combination of treatments may be used. […] Limited disease (stages 1 to 3) usually treated with chemotherapy and radiation therapy (called chemoradiation). […] Extensive disease (stage 4) mainly treated with palliative chemotherapy, with or without immunotherapy. […] If you smoke or vape, you will be advised to stop before you start treatment for lung cancer. […] Your health care team may also suggest that you eat healthy foods and exercise before starting lung cancer treatment.
  • #118 Small Cell Lung Cancer Treatment (PDQ®) – PDQ Cancer Information Summaries – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/books/NBK65909/
    The combination of platinum and etoposide is the most widely used standard chemotherapeutic regimen. […] SCLC is highly radiosensitive and thoracic radiation therapy improves survival of patients with LD and ED tumors. […] Prophylactic cranial irradiation prevents central nervous system recurrence and may improve the long-term survival of patients with good performance status who have responded to chemoradiation therapy. […] Combined-modality treatment with etoposide and cisplatin with thoracic radiation therapy (TRT) is the most widely used treatment for patients with limited-stage disease (LD) SCLC. […] Patients with LD have improved long-term survival with combined-modality therapy. […] Patients diagnosed with LD who smoke should be encouraged to stop smoking before undergoing combined-modality therapy because continued smoking may compromise survival.
  • #119 Lung cancer – Symptoms and causes – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/lung-cancer/symptoms-causes/syc-20374620
    Once lung cancer has spread beyond the lungs, it’s generally not curable. Treatments are available to decrease symptoms and to help you live longer. […] Quitting reduces your risk of lung cancer, even if you’ve smoked for years. […] Talk to your healthcare team about strategies and aids that can help you quit. Options include nicotine replacement products, medicines and support groups. […] If you’ve had radiation therapy to the chest for another type of cancer, you may have an increased risk of developing lung cancer. […] Follow your employer’s precautions. For instance, if you’re given a face mask for protection, always wear it. Ask your healthcare professional what more you can do to protect yourself at work. Your risk of lung damage from workplace carcinogens increases if you smoke. […] Cancer that spreads can cause pain, nausea, headaches or other symptoms depending on what organ is affected.
  • #120 Lung Cancer – UChicago Medicine
    https://www.uchicagomedicine.org/cancer/types-treatments/lung-cancer
    Thoracic surgeon Jessica Donington, MD, is an expert in minimally invasive and robotic lung cancer surgery and serves as Chief of the Section of Thoracic Surgery. […] Most patients with lung cancer need more than one type of therapy as part of their care plan. Patients at the University of Chicago Medicine have access to a full range of treatment options, including surgery, radiation therapy and chemotherapy, well as clinical trials of the newest targeted treatments, including immunotherapies. […] Our molecular pathology lab searches across more than 1,000 genes to screen for these mutations for every patient with lung cancer. Therapy can then be matched, or targeted to, the specific genetic changes in each tumor. […] UChicago Medicine lung cancer surgeons are board-certified thoracic surgeons who focus on treating diseases only of the lung and chest. They perform surgery using minimally invasive techniques, which results in smaller scars, less pain and fewer complications after surgery as compared to traditional open procedures.
  • #121 Lung Cancer Treatment Advancements with Yale expert Dr. Roy S. Herbst < Yale School of Medicine
    https://medicine.yale.edu/news-article/lung-cancer-treatment-advancements-with-yale-expert-roy-s-herbst-md/
    Early lung cancer can be treated with surgery. That means you have to find it early. […] When its early you can surgically remove it. […] Remember, its not lung cancer, its lung cancers, plural. Everyones cancer is different. […] Now, we can take the tumor, get a biopsy, and send it off to the lab and we actually look at genetic alterations that cause the cancer and then we personalize the treatment to the patient and the tumor. Identifying specific mutations like EGFR (epidermal growth factor receptor) or ALK (anaplastic lymphoma kinase) can lead to targeted therapies that significantly improve patient outcomes. […] The right treatment at the right time makes a difference. […] Screening can detect lung cancer early, making it easier to treat. Despite its importance, only a small percentage of eligible people get screened due to complexities in lung biopsy procedures and previous issues with insurance coverage. Increasing awareness and accessibility is crucial.